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Abstract 
Early events in the viral replication cycle of the human immunodeficiency 
virus (HIV) determine the virus' ability to sustain a persistent infection in 
susceptible host species. However, many of the molecular machinations through 
which the virus progresses during its earliest moments in the cell's interior 
remain enigmatic. Similar to other virus families, HIV virions are packed with a 
specific assortment of viral and cellular proteins that allow them to carry out 
their unique program for replication inside of target cells. One such protein that 
is present in incoming virions, HIV-1 integrase, is an enzyme that facilitates the 
fusion of the viral genome and the host genomic DNA in the nucleus, thereby 
making HIV a permanent fixture in infected individuals. We have discovered 
that, in addition to its role in catalyzing integration, the HIV-1 integrase plays a 
key part in transporting the viral DNA through the cytoplasm to the nucleus 
during a process known as viral nuclear import. Viral nuclear import is a key 
early step in the viral life cycle directly preceding integration that has to date not 
been exploited as a target for antiretroviral therapy. Our recent studies indicate 
that a small stretch of sequence within the carboxyl terminus of the HIV-1 
integrase protein contains a nuclear localization signal (NLS) that is 
indispensable for viral nuclear import and therefore absolutely required for 
productive HIV infection. Importantly, we have identified several mutations 
ii 
(NLS mutants) within this region that can disrupt nuclear import and therefore 
completely stall HIV infection. In addition, alignment of all the known subtypes 
of HIV within the region specified by our NLS mutants indicates that the virus 
seldom changes its sequence in this part of its genome, suggesting that this 
domain is a critical factor that it must preserve for optimal infection. Thus, a 
major focus of this thesis is to clarify the role that the HIV integrase plays in viral 
nuclear import. In turn, these analyses may provide a rational basis for the 
design of new experimental drug screening systems dedicated to finding 
inhibitors that block HIV-1 nuclear import and curtail HIV infection. A secondary 
aim of this work is to understand the mechanism of species-specific restriction of 
lentivirus infection in primates mediated by endogenous host cell restriction 
factors such as Lvl/TRIM5-a. Lastly, a potential role for non-pathogenic viral 
DNA episomal circles formed from integration-defective HIV virions as a novel 
platform for gene therapy based vaccines is discussed. 
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C h a p t e r i. Introduction 
Background: Biology of HIV-1 Infection 
I. HIV-1 natural history, phytogeny, and structural organization 
The human immunodeficiency virus (HIV) belongs to a family of viruses called 
the retroviridae, more specifically, to a subgroup known as lentiviruses. In 1983, 
HIV was discovered to be the etiological agent of acquired immunodeficiency 
syndrome (AIDS), a debilitating clinical condition which gradually erodes the 
immune system leading to increased susceptibility to opportunistic infections, 
and eventually, to death in infected patients. When HIV was first isolated by Luc 
Montagnier, Franciose Barre-Sinousi, William Rozenbaum and colleagues at the 
Pasteur Institute from a lymph node biopsy taken from a patient presenting the 
early clinical symptoms of AIDS, and shown by Robert Gallo and colleagues at 
the NCI to have reverse transcriptase activity (a hallmark of all retroviruses), it 
became only the second retrovirus discovered to infect humans (the first being 
the Human T-cell Leukemia Virus (HTLV I and II), whose discovery preceded 
that of HIV by just three years) [1, 2]. At first, HIV was thought to represent a 
new subtype of Human T-cell Leukemia virus, and was dubbed HTLV-III. 
However, while these two human retroviruses both share a characteristic tropism 
of CD4-bearing cells, they differ greatly in physical appearance, molecular 
structure, and pathogenicity. It was later discovered that HIV more closely 
resembles other known animal lentiviruses (including equine infectious anemia 
virus EIAV, Visna virus, feline immunodeficiency virus FIV, and simian 
immunodeficiency virus SIV) in structure, cell tropism, and replication kinetics 
within infected cells [reviewed in [3, 4]]. These viruses, which derive their name 
from the Latin term for slow ("lenti-"), accordingly cause chronic, persistent 
infections that cause immune dysfunctions and neurological disorders in a 
diverse array of animals including sheep, horses, cats and monkeys. 
Consequently, the current global HIV epidemic is thought to have begun with a 
zoonotic transmission of an SIV virus from a primate species in Central Africa 
(most likely SIVcpz from chimpanzees) in an area where there is close contact 
between humans and non-human primates. Indeed, there is a high prevalence of 
these SIV viruses in feral populations of many African monkey species, including 
those strains related to SIVcpz, which is believed to have entered humans via the 
monkey butcheries found in locations where these animals are used as a food 
source for the native human population [5]. Figure 1 shows the phylogenetic 
relationships between the known SIV viruses and highlights the relatedness of 
SYVcpz to the current HIV-1 virus responsible for the current AIDS pandemic. 
Four different primate species are shown, rhesus macaques, chimpanzees, 
humans, and owl monkeys, all of which have different susceptibilities to HIV 
infection depending upon the endogenous retroviruses (which provide the basis 
for the differentiation of host cell restriction factors like Lvl/TRIM5-(x) that they 
naturally harbor. Incompatibility of cellular receptors for the virus envelope as 
well as varying levels of innate immunity to immunodeficiency viruses may also 





















Figure 1. Natural history of HIV/SIV infection of primates. A ) A 650-bp pol fragment 
w a s amplified from monkeys representing seven different primate species, sequenced, 
then subjected to phylogenetic tree analysis by the neighbor-joining method. The 
positions of 21 SIV sequences (in color) are s h o w n in relation to HIV/SIV reference 
sequences from the Los Alamos HIV/SIV Sequence Database (in black). It is thought 
that the current H I V pandemic emanated from zoonotic transfer of such primate SIVs 
from practices such as bushmeat butchery. B) Pictures of an owl m o n k e y (Aotus 
trivirgatus), rhesus macaque (Macaca mulatto), chimpanzee (Pan troglodytes), and h u m a n 
(Homo sapiens) are shown. Depending on the ancestral retroviruses that each of these 
primate species harbor, they have varying degrees of natural resistance to H I V or SIV 
viruses due to the presence or absence of antiviral factors such as Lvl/TRIM5-alpha. 
[Adapted from reference 240]. 
II. Molecular biology of HIV-1 infection and pathogenesis 
With a single-stranded, positive-sense 9.8 kilobase RNA genome, two copies 
per virion, HIV shares many characteristics with other known retroviruses, such 
as the presence of dedicated genes for structural (gag), enzymatic (pol), and 
membrane targeting (env) activities. However, the specific molecular pathways 
that HIV uses to infect its target cells are complex and enigmatic, and combined, 
they enable the virus to do things that other retroviruses cannot, such as infect 
non-dividing cells. The complexity of HIV replication cycle is undoubtedly the 
result of the unprecedented number of genes, nine in total, that HIV specifies and 
the plurality of functions that these viral gene products carry out within host 
cells. In addition to the standard three retroviral genes (gag, pol, and env), the HIV 
genome encodes at least six other accessory genes (tat, rev, nef, vif, vpr, and vpu/ 
vpx), the most of any known retrovirus. Figure 2 shows the genetic organization 
of the HIV-1 genome with the locations of the currently known viral proteins 
indicated. As we gain more knowledge about the biological functions of all of 
HIV viral gene products, specifically how they interact with each other and host 
cell factors to promulgate productive infections with this virus inside of its target 
CD4+ cells, we will be better able to design new antiviral therapies to block its 
replication and eradicate AIDS. HIV virions are typically 100 nanometers in 
diameter and are indistinguishable from other lentiviruses under an electron 
microscope. Their cone-shaped capsids contain the diploid viral genomic R N A 
along with associated viral enzymes reverse transcriptase, 
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Figure 2. Virion structure a n d genetic organization of HIV-1. A ) A cross-section of an 
H I V virion with the predicted location of all k n o w n viral proteins and phospholipid 
bilayer s h o w n . B ) T h e location of the long terminal repeats (LTRs) and the genes 
encoded b y HIV-1 are indicated. G a g , Pol, and E n v proteins are initially synthesized as 
polyprotein precursors. T h e G a g precursor is cleaved b y the viral protease (PR) into the 
mature Gag proteins: matrix (MA, pl7), capsid (CA, p24), nucleocapsid (NC), and p6. 
The GagPol precursor undergoes proteolytic processing to generate the Gag structural 
proteins and the Pol enzymes: protease (PR, plO), reverse transcriptase (RT, p66/51) and 
integrase (IN, p32). The Env glycoprotein precursor, gpl60, is cleaved by a cellular 
protease during transport to the cell surface to generate the mature surface glycoprotein 
gpl20 and the transmembrane glycoprotein gp41. The sizes of the genes and encoded 
proteins are not drawn to scale. [Adapted from reference 239]. 
integrase, and protease. The viral capsid is surrounded by a phospholipids 
bilayer whose outside is studded with trimeric clusters of the viral envelope 
protein gpl60. Prior to its migration to the plasma membrane, the full-length 
gpl60 polyprotein is cleaved by cellular proteases into two distinct subunits, 
gpl20 (surface antigen, SU) and gp41 (transmembrane, TM), and these two 
proteins form into non-covalently linked heterodimers which assemble into 
stable trimeric complexes once at the virion surface. A brief description of each of 
the viral genes identified to date and overview of their proposed function(s) is 
described below. 
The HIV gag gene encodes a large 55 kD polypeptide which is cleaved by 
the viral protease into four smaller proteins: the p24 capsid protein (CA), the pl7 
matrix protein (MA), p9 nucleocapsid (NC), and the p6 protein. This 55 kD 
protein, often called the Gag precursor or Pr55, is myristylated at its amino 
terminal end, which allows it to remain embedded in the cells phopholipid 
bilayer at the interior cytoplasmic side while it is cleaved into p24, pl7, p9, and 
p6 as the virions bud. Myristylation of the Gag precursor is required for the 
production of viable virions and mutants which are defective for Pr55 
myristylation fail to replicate [6]. As the myristylated Gag precursor accumulates 
in increasing quantities at the plasma membrane, viral particles begin to form 
and undergo the process of "budding" from the cell into many discrete virions 
[reviewed in [7]]. The full length viral genomic RNA is recruited to these 
membrane localized Gag precursor assemblies through its interactions with NC, 
which binds to the packaging sequence found in the 5' end of the RNA [8]. The 
NC protein has also been shown to non-specifically bind RNA, and it is thought 
that the diploid RNA strands encapsidated in the virion are afforded a protective 
coating of NC protein. 
As the viral particles bud from the plasma membrane, several viral proteins 
are responsible for creating the mature infectious virions that attack new 
uninfected cells. The most prominent of these is the HTV protease (PR) which 
auto-catalytically releases itself, then cleaves the Gag-Pol precursor protein into 
its active components MA, CA, NC, p6 and the viral enzymes reverse 
transcriptase (RT) and integrase (IN), and more PR [reviewed in [9,10]]. The pl7 
MA protein aids in the formation of mature infectious virions by stabilizing the 
envelope protein at the plasma membrane through its binding of the cytoplasmic 
tail of gp41 [11]. Recent results suggest a mechanism by which binding of the 
gp41 cytoplasmic tail to Gag within immature HIV-1 particles inhibits Env 
conformational changes on the surface of the virion that are required for proper 
viral membrane fusion with target cells [12]. This "inside-out" regulation of HIV 
-1 fusion could play an important role in the virus life cycle by preventing the 
entry of immature, noninfectious particles [12]. 
Lastly, viral budding is completed by the membrane fission that is 
mediated by the p6 protein from Gag. The p6 protein binds to a protein that is 
normally involved in vesicular trafficking within cells called TsglOl [13-15]. The 
p6 protein of HIV interacts with TsglOl via its PTAP motif (Pro-Thr-Ala-Pro) or 
"late domain", and it is believed that this interaction allows the virions to bud 
with the help of the ESCRT I complex (endosomal sorting complex required for 
transport I (II and III)) which coordinates the multi-vesicular body pathway that 
recycles endosomes during normal cellular metabolism [reviewed in [16-18]]. 
Thus, consistent with its role as an obligate intracellular parasite, HIV makes 
efficient use of common cellular processes for sorting endosomes to facilitate its 
release from infected cells. Once the immature virions are released from the cell 
surface, the viral protease reaches a critical mass inside the budded virions and 
increased proteolysis of Gag precursors causes the condensation and assembly of 
p24 CA proteins that results in the structural formation of the mature virion core. 
A diagram of the complete HIV-1 life cycle is shown in Figure 3. 
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Figure 3. Overview of the HIV-1 life cycle. A ) Electron micrographs of HIV 
virions (blue) attacking a CD4+ T cell (pink). B) A schematic diagram of HTV replication 
inside of an infected T cell is shown. Following attachment to the cell surface via CD4-
gpl20 binding /chemokine receptor engagement, envelope-mediated membrane fusion 
ensues. After fusion, the virion core enters the cytosol and undergoes a series of 
molecular interactions called "uncoating" and reverse transcription complexes (RTC) 
form allowing reverse transcription to occur. During or shortly after reverse 
transcription, R T C bind cellular proteins such as H M G I(Y) and become pre-integration 
complexes (PIC). PIC contain at a minimum IN, Vpr, and the viral D N A and are capable 
of traversing the N P C and entering the nucleus, where integration occurs. The "early 
phase" of the life cycle is complete after integration, then both full length and spliced 
viral R N A is transcribed, exported by Rev, translated by cellular machinery, and 
assembled at the plasma membrane facilitating the budding of new infectious virions. 
[Adapted from reference 113]. 
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III. Regulation of the early events in the life cycle of HIV-1 
As infection commences, HIV virions are drawn to the CD4+ molecules that 
adorn the surface of T cells via the interaction with the CD4 binding domain of 
gpl20. After CD4-gpl20 binding, the bound envelope protein undergoes a series 
of conformational changes that allows it to bind chemokine receptor molecules 
that are also present at the cell surface in these cells [19]. Generally, HIV relies 
on either of two 7-transmembrane G-protein coupled chemokine receptors, CCR5 
or CXCR4, as the co-receptor after CD4 engagement, but viruses that use other 
chemokine receptors, such as CCR2b, have also been described [20]. 
Determinants within the variable loops of the gpl20 envelope protein dictate 
which chemokine co-receptor the virus uses for entry, and a change in co-
receptor usage from CCR5 to CXCR4 is associated with more rapid progression 
to AIDS in chronically infected patients [20, 21]. Once chemokine receptor 
binding has occurred, the gp41 transmembrane domain of HTV env achieves a 
fusogenic state, which is marked by its insertion into the cell membrane and the 
"zippering" of so called heptad repeat motifs that serve to bring the viral and cell 
membranes into close proximity until membrane fusion occurs [22, 23]. 
After fusion of the viral and cell membrane has occurred, the HIV core 
consisting of the p24 CA protein, the diploid viral RNA coated with the p9 NC 
protein, along with the viral enzymes RT and IN, p6 and Vpr, enters into the 
12 
cytosol and a mysterious series of molecular events known as "uncoating" 
ensues. The process of HIV-1 fusion and uncoating is depicted in Figure 4 below. 
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Figure 4. HIV gp-120-CD4/co-receptor binding, fusion/entry, uncoating and PIC 
formation. A) A schematic diagram of HIV envelope (gpl20/gp41) protein binding CD4 
on the surface of target cells, then exposure of the co-receptor binding site, binding to co-
receptor (CCR5 or CXCR4), fusion peptide insertion into cell membrane, zippering of 
heptad repeats, and resulting membrane fusion. B) Depiction of the early events of the 
HIV life cycle immediately following viral fusion/entry. Upon entering the cytoplasm 
of the infected cell, the virion core disassembles during "uncoating", presumably unless 
blocked by the binding of host restriction factors (Lvl/TRIM5alpha) to the CA. Once 
uncoating is finished, the virion reassembles into macromolecular structures for reverse 
transcription (RTC) and nuclear import (PIC). These large sub-viral structures likely 
containing host cell proteins (such as H M G I(Y)) and interact with cellular nuclear 
import machinery in an unknown manner to cross the nuclear pore complex and 
integrate into the host chromosomal DNA. [Adapted from ref 241]. 
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During uncoating, the p24 C A shell unravels and the remaining viral proteins 
reorganize themselves to form specialized structures known as reverse 
transcription complexes (RTCs) and pre-integration complexes (PICs) [reviewed 
in [24-26]]. Certain cellular molecules may also be a part of these complexes and 
they may bind to structural components of the cell such as actin filaments and 
microtubules [26-28]. The precise composition of these sub-viral complexes has 
been a matter of contention within the field, and a detailed discussion will follow 
below. Suffice it to say, these intermediate complexes provide the context in 
which reverse transcription occurs in the cytosol of the infected cell and it is 
widely believed that the processes of uncoating and reverse transcription are 
intricately coordinated. 
All retroviruses specify an RT enzyme that allows them to convert their viral 
RNA genomes into a double stranded viral DNA intermediate that serves as the 
substrate for integration into the host genome. HIV is no different, and its RT is 
an RNA- and DNA-dependent DNA polymerase that makes a cDNA copy of the 
plus-stranded RNA genome from the incoming virion, then uses this cDNA as a 
template for second-strand synthesis to make the full length double stranded 
viral DNA ready for integration. The first step of HIV reverse transcription 
begins when a lysine transfer RNA (tRNA) molecule binds to a stretch of 
sequence near the 5' end of the genome known as the primer binding site (PBS) 
15 
[reviewed in [29-33]]. From this primer, RT synthesizes a short stretch of D N A , 
while degrading the copied RNA in the newly-formed RNA-DNA hybrid. Next, 
by virtue of direct repeat regions located at each end of the viral RNA, this short 
stretch of newly synthesized cDNA can shift its hybridization from the 5' end to 
the 3' end of the genomic RNA in a process known as "strand switching" or 
"strand transfer." This allows the synthesis of a full-length minus strand and, in 
the process, initiates the generation of the long-terminal repeats (LTR). There are 
polypurine-rich regions (PPT) encoded within the genomic RNA that are 
resistant to the RNase-H activity of reverse transcriptase. These regions prime 
plus-strand DNA synthesis on the nascent minus-strand, and the central PPT has 
been implicated in the enhancement of viral nuclear transport [34]. A second 
strand-transfer is required to complete DNA synthesis. Successful initiation of 
reverse transcription requires both the correct positioning of the amino-lysyl-
tRNA primer at the PBS, as well as the relaxation of the secondary structure of 
the viral RNA. The accessory protein Vif and the viral nucleocapsid (NC) assist 
in the completion of these two vital processes [7, 35]. 
When reverse transcription has been completed, the viral genome has to 
navigate through the viscous cytoplasmic milieu of the cell and somehow 
translocate across the nuclear pore into the nucleus in order to access the host cell 
chromatin, where integration subsequently occurs. As the viral genome and the 
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estimated size of the sub-viral reverse transcription and pre-integration 
complexes exceeds the known 50 kD (25 nm) exclusion limit of the mammalian 
cell nuclear pore [25, 36], it is unlikely that HIV nuclear import occurs by passive 
diffusion. Indeed, the precise composition of the sub-viral complexes that HIV 
forms once it enters the cytoplasm has been a topic of great contention and the 
process of HIV nuclear import remains ill-understood. As nuclear import is a 
key step in the early events of the viral life cycle and a major topic of this thesis, 
the composition of these sub-viral complexes and the proposed karyophilic 
properties of the individual viral proteins will be discussed in more detail in the 
sections to follow. After the viral DNA successfully localizes to the nucleus, it 
targets chromosomal DNA where the viral IN enzyme catalyzes the insertion of 
the HTV-1 genome into that of the host cell [37]. While it is widely held that 
retroviral integration occurs at random spots on the host genomic DNA, recent 
reports have suggested that HIV-1 displays a preference to insert its genome into 
actively transcribed genes [reviewed in [38]]. The strand transfer reaction 
catalyzed by the HIV IN allows the ends of the reverse transcribed viral DNA, 
which have had two nucleotides removed by the enzyme's 3' processing activity, 
to effect a nucleophilic attack of the chromosomal DNA, creating a gapped (at 
each end) partially integrated intermediate. This gapped integration 
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intermediate is then filled in by host D N A repair enzymes [39], and the fully 
integrated retroviral DNA is called the provirus. 
Once in the nucleus, an alternative fate of the viral DNA is also possible 
that allows for the covalent fusing of the viral DNA ends by enzymes involved in 
the non-homologous DNA end joining pathway, resulting in the circularization 
of the HIV genome [40]. These covalently closed circular viral DNA 
intermediates are called 1- and 2-LTR circles, and they were previously thought 
to be labile byproducts of failed HIV integration attempts. However, these viral 
episomes have unusual properties, such as their longevity inside of infected cells 
and their ability to express limited quantities of certain early viral genes, and 
Chapter 4 of this thesis highlights their potential use in gene therapy settings. 
While these 2-LTR circles appear capable of expressing small quantities of HIV 
Tat and Nef [reviewed in [41] and [42]], they are unable to sustain a productive 
infection in HIV permissive cells and they do not cause overt toxicity. 
Although unintegrated viral DNA templates are capable of driving limited 
viral gene expression, the vast majority of HIV protein expression following 
integration and formation of the proviral state is the result of active transcription 
from the integrated viral DNA template. As the topic of this thesis involves the 
early events of the viral life cycle that precede the transcription of viral genes, 
these steps of the viral life cycle will be discussed briefly below. In the integrated 
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HIV template, the 5'LTR serves as the major promoter-enhancer for viral gene 
expression. The 5' LTR sequence possesses several regions (also present in the 3' 
LTR) that are recognized by common cellular transcription factors such as NFkB, 
Spl, NFAT-1, and Ap-1 as well as a defined TATAA box. The defined unit that 
serves as the 5'LTR promoter includes a trio of binding sites for the constitutively 
expressed transcription factor Spl, followed by the TATAA box and the 
transcription initiator element. Despite the presence of these transcriptional 
elements, the 5'LTR is in general a weak promoter of viral gene expression on its 
own [reviewed in [43]]. However, the presence of the transactivator protein (Tat), 
and its subsequent binding to the transactivation response (TAR) element, a 59-
nucleotide stem-loop structure specified by the R region of the LTR [44], 
dramatically increases the effectiveness of the 5'LTR promoter, and viral gene 
expression following Tat-TAR complex formation increases one thousand-fold or 
more [45]. The Tat-TAR complex acts in concert with the cellular factor cyclin T, 
which recruits the cyclin-dependent kinase CDK9 to assemble the positive 
elongation factor b (pTEF-b) complex at the transcriptional start site of the viral 
template [46]. Recruitment of the pTEF-b containing the CDK9 kinase results in 
the hyper-phosphorylation of RNA polymerase II, allowing it to firmly attach 
and stimulate transcriptional elongation to form the viral RNA transcripts. As is 
the case for the transcription factors NFkB and NFAT-1, both cyclin T expression 
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and pTEF-b complex activity are up-regulated in activated T cells [reviewed in 
[47]], reinforcing the notion that HIV enjoys a transcriptional advantage in these 
cells which may at least in part explain the virus' selection of this compartment 
as the major site for its replication. 
Both unspliced and multiply-spliced viral RNAs are transcribed from the 
integrated provirus. As the cell tends to retain incompletely-spliced, intron-
containing mRNAs in the nucleus, HIV developed a system to ensure that its full 
length unspliced genomic RNA and partially-spliced RNA transcripts can make 
it to the cytosol. The viral Rev protein binds to a cis-acting RNA element called 
the Rev-response element (RRE) that interacts with the cell's nuclear export 
machinery to shuttle unspliced or partially spliced viral RNA out of the nucleus 
and into the cytoplasm [48]. Rev itself is imported to the nucleus from the 
cytoplasm via direct interaction of its nuclear localization signal with the soluble 
nuclear import receptor karyopherin 3 [49]. As Rev and the unspliced RRE-
bearing viral RNA accumulates in the nucleus, the nuclear export karyopherin, 
Crml (chromosome region maintenance protein 1) attaches to the Rev-RRE-RNA 
complex along with RanGTP and actively transports the viral RNA through the 
nuclear pore complex where it gains access to the cytosol. Once in the cytosol, 
the cellular protein RanGAPl stimulates the hydrolysis of the attached RanGTP 
to RanGDP, and the exported viral RNA is released into the cytoplasm, where it 
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is free to attach to the Gag proteins that accumulate on the cytoplasmic side of 
the cell's plasma membrane during virion assembly as described above. 
Composition and Karyophilic Properties of the HIV Pre-integration Complex (PIC) 
The nucleus is the largest membrane bounded compartment within 
eukaryotic cells, and a substantial amount of cellular energy is devoted to the 
shuttling of protein and ribonucleoprotein complexes through the nuclear pore 
complex (NPC)—the negotiable gate between the nuclear cytoplasmic 
compartments. After fusion and entry of its target cells, the Human 
Immunodeficiency Virus (HIV-1) must navigate its genome through the cytosol 
to the NPC and then into the nucleus where integration into the hosf s 
chromosomal DNA subsequently occurs [50, 51]. Although this property is 
essential to the virus' ability to infect its target cells, neither the precise 
mechanism of its nuclear import nor the identity of the cellular factors and viral 
determinants that are essential for it have been deciphered. For HIV-1, the study 
of this process is not only of immense academic interest, but also of significant 
medical relevance, as its clarification could lead to new therapeutic targets and 
novel treatments for HIV disease. 
It has long been known that the viral genome is contained in a large 
nucleoprotein complex during reverse transcription of the viral RNA into its 
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cognate D N A copy—a process that appears to be complete before viral nuclear 
entry. This assembly of viral and host constituents is operationally defined as the 
pre-integration complex, or PIC [26]. The PIC is capable of traversing the 
cytoplasm, entering the nucleus, and targeting host chromatin. Once in the 
nucleus, the viral integrase protein (IN), assisted by the action of host enzymes, 
catalyzes the insertion of viral DNA into that of the host and subsequent repair of 
the chromosomal interruptions created by the integration event. 
The PIC, and the reverse transcription complexes that precede it in the 
viral life cycle, likely constitute a series of structural and functional intermediates 
with changing composition. In fact, a variety of nucleoprotein complexes having 
different sedimentation velocities have been isolated from the cytoplasm and 
nucleus at specific times post-infection [52]. Not surprisingly, attempts to 
characterize the viral and cellular protein components of PICs using biochemical 
approaches have yielded disparate results. Integrase is consistently found as a 
constituent of the PIC, as would be expected for a viral protein that performs 
obligate catalyses on the viral DNA substrate in both the cytoplasm and nucleus. 
Other PIC-associated viral proteins include matrix (MA), Vpr, and, less 
frequently reported, nucleocapsid, capsid, and reverse transcriptase (RT) [26, 36, 
53,54]. 
22 
A facilitating role in the nuclear import of the viral genome has been 
attributed to a number of PIC components, including MA, Vpr, IN, and elements 
in the viral DNA itself. Nevertheless, assignment of the relative importance of 
each remains controversial. While some studies have implicated MA as a 
mediator of infection in non-dividing cells [55, 56], others have shown that 
infection with viruses that are altered in MA proceeds efficiently in the absence of 
either proposed karyophilic determinants within MA [57-59] or the majority of 
the MA protein [60]. In addition, while the ability of Vpr to interact with the 
nuclear pore complex has been well documented [61, 62], and varying degrees of 
block to viral replication have been observed in its absence [63, 64], virions 
lacking both Vpr and the proposed NLS regions in MA can still efficiently infect 
non-dividing cells [54, 59]. Recent studies using confocal and electron 
microscopy to visualize the fine structure of HTV reverse transcription complexes 
(RTCs), a conglomerate that is believed to be a substructure of the PIC, confirmed 
the presences of Vpr and IN within RTCs at 3 to four hours post infection with 
VSV-pseudotyped HIV vectors [25]. 
A role in PIC nuclear import has also been attributed to the central DNA 
flap—a discontinuity of the plus-strand of the HIV genome consisting of a 99 
basepair region of triple helix viral DNA, which apparently acts in cis to enhance 
nuclear targeting of the incoming PIC [65]. Viruses lacking this central DNA flap 
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are not compromised for reverse transcription, but exhibit a slight 2-5 fold defect 
in nuclear import [34]. Addition of the central DNA flap synthesis in lentiviral 
vectors that normally lack the structure increases their ability to transduce a 
variety of cell and tissue types in vitro [34] and in vivo [66]. However, recent 
experiments suggest viruses lacking the central DNA flap exhibit near wild-type 
levels of nuclear uptake under a variety of experimental conditions, and the 
effects of this viral structure on nuclear import may be cell type-specific and less 
significant than originally thought [67, 68]. 
The final PIC component with reported karyophilic activity is integrase. 
Although an initial study characterized the intracellular localization of an IN-p-
galactosidase fusion protein as cytoplasmic [69], further work using both 
transient transfection and in vitro nuclear import assays has shown that IN 
localizes predominantly to the nucleus [70-73]. One study reported that the 
mutations K186Q and Q214LQ216L prevent the import of isolated IN or of other 
PIC-associated proteins (and presumably of the PIC itself) in assays performed in 
vitro [54], however, others have observed wild-type accumulation of nuclear 
forms of viral DNA in the presence of these mutations [70, 74-76]. In a more 
recent study, a peptide spanning amino acids 161-173 of IN was reported to act as 
a transferable NLS. Mutations at residues V165 and R166 abrogated the nuclear 
localization of an IN-pyruvate kinase fusion protein and, in the context of 
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infection, impaired the accumulation of viral D N A in the nuclei of both dividing 
and non-dividing cells [77]. Again, the interpretation of these results has been 
challenged [78] and reassessed, and it was discovered that the V165 and R166 
mutations have pleiotropic effects on the early viral life cycle (generally at the 
step of reverse transcription) which overshadow their previously described 
defects in nuclear import [67]. Thus, the precise mechanism of HIV nuclear entry, 
as well as the identity of the cellular factors and viral determinants that are 
essential for it, remains elusive. 
Cellular proteins that have been associated with the PIC include the high 
mobility group protein HMG I(Y) and another protein called barrier to auto-
integration factor 1 (BAF). HMG I(Y) is believed to bind to the reverse 
transcribed viral DNA contained in the PICs and may facilitate the histone-like 
winding and "coiling" of the PIC DNA, reducing its size from the approximated 
3.3 microns if it were unwound, to the 56 nm estimated diameter of the PIC 
[reviewed in [28, 79]. The BAF protein is thought to prevent the viral DNA from 
integrating into itself in an intramolecular fashion and can enhance the catalytic 
activity of salt-stripped PICs in vitro, though it is unclear whether this molecule is 
directly associated with the incoming PIC and its relative importance to the viral 
life cycle is unknown[80]. Other proteins reported to associate with the incoming 
PIC include chromatin remodeling proteins such as SNF5 (INI-1) and PML [81]. 
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Nuclear Import Overview 
I. Structural features and functional relevance of the nuclear pore complex (NPC) 
The mammalian cell nucleus is a key adaptation that marks the evolutionary 
divergence of eukaryotic cells from lower level organisms. Accordingly, a 
substantial amount of cellular energy is devoted to the shuttling of protein and 
ribonucleoprotein complexes into and out of the nucleus, through the nuclear 
pore complex (NPC)—the negotiable gate between the nuclear and cytoplasmic 
compartments. While the nucleus appears to be a bounded compartment under 
the light microscope, under the electron microscope it appears dotted with 
numerous holes, which are the nuclear pore channels. An electron micrograph of 
a mammalian cell nucleus is shown in Figure 5 along with a higher magnification 
image of nuclear pores from an amoeba (dictyostelium discoideum). The outer 
nuclear membrane is contiguous with the endoplasmic recticulum (ER) 
membrane, while the inner nuclear membrane encapsulates the host cell 
chromatin. The points at which these two membranes meet and interconnect are 
the junctions where nuclear pores form [shown in Figure 6], giving rise to the 
avenues of molecular transport between the cytoplasm and the nucleoplasm that 
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Figure 5. Electron micrographs of the fine structure of the vertebrate NPC. A) Cryo-
electron micrograph of a mammalian cell with visible nuclear pores (black circles). B) 
Electron micrograph N P C from a soil-dwelling amoeba, Dictyoselium discoideum, with 
views from both the cytoplasmic and nuclear side of the N P C indicated (diagram). The 
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Figure 6. Diagram of the Nuclear Pore Complex (NPC). A) The N P C allows passive 
diffusion of ions and small molecules. Nuclear proteins, RNAs, and ribonucleoprotein 
(RNP) particles larger than ~9nm are selectively and actively transported through NPCs 
by a signal-mediated and energy-dependent mechanism called nuclear import. B) 
Surface renderings of the nuclear pore complexes revealing the central framework, 
which exhibits strong 8-fold symmetry and thus consists of two identical halves relative 
to the central plane of the nuclear envelope. [Adapted from references 43 and 44]. 
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Structurally, the N P C is immaculate in its design—a macromolecular structure of 
over 125 mega Daltons composed of constant as well as static constituent 
proteins that interact dynamically to govern traffic into and out of the cell 
nucleus. The basic structure and function of the NPC has been preserved 
throughout its evolution, with a high degree of homology evident between yeast 
(the first cells to develop a distinct nucleus) and higher eukaryotic cells [82]. The 
mammalian NPC is comprised of a set of at least 30 different proteins, 
collectively termed nucleoporins [83]. The NPC displays eight-fold rotational 
symmetry, therefore every nucleoporin is present at a copy number of either 8 or 
an integer multiple of 8 [82, 84]. These proteins often contain amino acid 
sequence motifs of phenylalanine and glycine dipeptide repeats (FG repeats), 
which are believed to mediate the main interactions between nucleoporins and 
the soluble transport receptors that carry out nuclear transport. 
When viewed from the top-down, the nuclear pore looks like a wagon wheel 
with eight spokes, each at a 45-degree angle. Indeed, phenylalanine-glycine 
dipeptide repeats or variations thereof (i.e. GLFG or FXFG) are present in nearly 
half of all of the nucleoporins identified, leading to the commonly used 
nomenclature for them as "FG nups." These FG nups come in numerous shapes 
and sizes. Some are long, filamentous proteins with multiple domains and 
enzymatic activity, such as the cytosolic Nup358. Others line the core of the 
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central channel and are more compact, such as Nup62. Regardless of their shape 
or size, the FG nups that comprise the NPC are all oriented with their FG repeats 
facing the interior of the nuclear pore channel, forming a pathway of FG repeats 
for soluble nuclear import factors, such as the karyopherins (also called 
importins), to interact with as they transport their cargo across the nuclear pore. 
The precise mechanism for FG nup-mediated nuclear translocation is unknown, 
however several models have recently been proposed to explain this 
phenomenon. Nuclear translocation occurs against a concentration gradient, and 
kinetic studies have indicated that a single NPC can accommodate a mass flow of 
up to 80 million Daltons per second, corresponding to about 1000 translocation 
events per second per NPC [reviewed in [85]]. 
One model of nuclear translocation that has been proposed is the "Brownian 
Affinity Gating" model [86]. This model suggests that a given polypeptide 
moving in a rapid and random fashion through the cytolsol must pay an entropic 
price for gaining access to the central channel of the nuclear pore, and, once 
there, remains in a 'transition state' for nuclear translocation [86]. The larger the 
protein, the higher the entropic penalty for its gaining access to this transition 
state, and the lower its probability to passively diffuse through the NPC. For 
large proteins, active transport across the NPC is mediated by the interactions of 
the FG nups (which line the interior of the NPC and stretch from the cytosolic to 
30 
the nuclear compartments of the pore) with soluble transport factors that bind to 
NLS containing large proteins, acting in a concerted 'enzymatic' fashion to help 
the large proteins overcome the entropic barrier to nuclear translocation. 
Another model is the hydrophobic exclusion or "selective gate" model [87]. 
This model suggest that the FG nups which line the central channel of the 
nuclear pore create a hydrophobic environment that acts as a barrier to keep 
large, hydrophilic proteins out. Macromolecules containing NLS sequences, and 
therefore bound by soluble import factors such as the karyopherins would be 
chaperoned across the pore by locally disrupting the hydrophobic "gate", 
creating a selective partition for the molecule to pass through [87, 88] . A major 
difference between the Brownian affinity gating and the hydrophobic selective 
gate theories is that the latter calls for weak interactions between the FG repeats 
themselves, while the former suggest that the FG repeats bind only to the 
karyopherin-bound cargo proteins that are being imported. In yet another 
proposed scenario, called the affinity gradient model, the FG nups are assembled 
as an array of interaction sites with progressively increasing affinities from the 
cytoplasmic to the nuclear sides of the NPC [89]. In this model, selective nuclear 
transport is ensured because non-karyopherin-bound cargo proteins would be 
unable to interact with FG nups and therefore would not undergo the cycles of 
association/dissociation with the nucleoporins lining the central channel and 
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would not be transported across the NPC. A shematic diagram of these 
proposed models of nuclear-cytoplasmic transport is shown in Figure 7. 
17. Soluble transport receptors and the Ran GTPase system 
For molecules that are too large to passively diffuse through the NPC, 
nuclear-cytoplasmic transport begins with the recognition and binding of such 
proteins by soluble transport receptors in the cytosol. Once these protein 'cargos' 
are bound by soluble transport receptors, the entire complex localizes to the 
nuclear compartment where it docks at the NPC [reviewed in [90, 91]]. These 
soluble transport receptors are called karyopherins (also referred to as importins, 
exportins and transportins) and they have the unique ability to bind to protein 
cargos that display a specific amino acid sequence, known as a nuclear 
localization signal (NLS) or nuclear export signal (NES), that determines the 
directionality of their transport through the NPC. Fourteen different 
karyopherins have been identified in the yeast S. cerevisiae, and at least 20 are 
estimated to exist in vertebrates, each with the potential to recognize a different 
NLS or NES [reviewed in [92]]. In addition, these karyopherins often exist in a 
and 3 isoforms, which form any number of different heterodimeric complexes 
capable of binding to different FG nuceloporins in the NPC. 
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Figure 7. Models of nuclear-cytoplasmic transport across the NPC. Schematic 
diagrams of the three leading proposed models for how nuclear transport occurs across 
the N P C are shown. A) The "oily spaghetti" model suggests that a karyopherin-cargo 
protein complex slides through a network of filamentous FG nucleoporins that normally 
excludes macromolecules that do not directly interact. These interactions m a y facilitate 
random movement of the karyopherin-cargo protein complex through the network of 
F G nups and ultimately across the NPC. B) The "hydrophobic exclusion" model 
proposes that the FG nups lining the central pore support weak hydrophobic 
interactions between one another that creates a barrier of hydrophobicity that non-
karyopherin bound proteins will be unable to cross. C) The "Brownian motion/Affinity 
gating" model suggests that the FG nups may provide a series of sequential binding 
sites of increasing affinity from the exterior to the interior of the N P C to which the 
translocating karyopherin-cargo protein complexes temporally attach. FG binding sites 
at the N P C faces create a high concentration of transport complexes near the N P C , 
increasing the probability that the translocating protein complexes will move across it by 
random diffusion. [Adapted from reference 112]. 
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Generally, it is thought that the karyopherin a molecules bind to the N L S 
containing cargo proteins, recruiting the karyopherin 3 molecules to form a 
transport complex of the three proteins—kapcx/kapP+NLS-containing cargo 
protein—which travels to the nucleus and crosses the nuclear pore through 
interactions with the FG nucleoporins that comprise the NPC. 
A small polypeptide known as Ran acts as a master regulator during nuclear 
import through its enzymatic conversion of GTP GDP, forming an energetic 
gradient across the pore [93]. In Figure 8a, a schematic model of the proposed 
mechanism of karyopherin-mediated nuclear-cytoplasmic transport is shown. 
Ran directly binds to karyopherins and acts as a molecular switch regulating 
karyopherin association / disassociation with cargo and constituent molecules of 
the NPC [reviewed in [90]]. 
During import, RanGTP binding to NLS-karyopherin complexes triggers 
cargo release in the nucleus, whereas for export, RanGTP stabilizes the 
karyopherin-cargo interaction, allowing the complex to exit across through the 
NPC [92]. A steep RanGTP/RanGDP gradient has been measured across the 
nuclear envelope and is key for dictating the directionality of transport [94]. This 
gradient is maintained by several essential Ran co-factors, such as RanGAPl, 
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Figure 8. Soluble transport receptors and the RanGTPase system. Nuclear import is 
carried out by soluble nuclear translocating receptors called karyopherins (also called 
importins or exportins) in conjunction with an energetic gradient of GTP hydrolysis 
catalyzed byt the small GTPase Ran. A) A schematic diagram of Ran-mediated 
karyopherin-assisted nuclear import is shown. A given cargo protein (light blue) 
bearing a functional NLS is bound by a complex of karyopherin alpha and beta (dark 
blue). The cargo protein complex is then shuttled through the central channel of the 
nuclear pore complex via the interactions of the bound karyopherins with the FG 
nucleoporins (purple) that comprise the NPC. Once inside the nucleus, the karyopherin-
bound cargo protein binds to RanGTP (red triangle) in the nucleus causing it to be 
released into the nucleus and allowing the unbound karyopherin complex to be recycled 
to the cytosol after RanGAP-mediated RanGTPRanGDP hydrolysis. B) RanGDP (pink) 
is then recycled to the nucleus by a molecule called NTF2 and is reloaded with GTP by 
RanGEF to begin another import cycle. [Adapted reference 111]. 
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RanGAPl, is the GTPase activating protein of Ran and it is found in on the 
cytoplasmic side of the NPC, where it greatly enhances Ran's inherent GTPase 
activity [95]. In the nucleus, the Ran guanine nucleotide exchange factor, RCC1, 
helps Ran trade GTP for GDP [96]. The activity of RanGAPl and RCC1 set up 
the RanGTP/RanGDP gradient across the NPC by maintaining a high 
concentration of RanGTP in the nucleus and a low concentration of RanGTP in 
the cytosol. Ran itself is rapidly shuttled into and out of the nucleus via 
interactions with exporting karyopherins and a small (lOkD) Ran binding protein 
called NTF2. NTF-2 binds to the GDP-bound form of Ran in the cytosol and 
relocalizes it to the nucleus through its interactions with the FG nups that line the 
NPC. RCC1 is associated with nuclear chromatin, and RCC1 mediated 
GTP GDP nucleotide exchange in this compartment causes the dissociation of 
NTF2-RanGDP, freeing up more Ran to bind GTP in the nucleus. While Ran is 
small enough (24kD) to passively diffuse across the NPC into the nucleus, NTF2-
assisted active transport of RanGDP enhances its import efficiency and ensures 
the proper distribution of Ran between the cytoplasm and nucleus [97]. For 
larger cargo protein cargos, there may be additional requirements for the 
RanGTPase system [98]. 
While Ran-independent mechanisms for NPC transport have been suggested 
(for example, during certain types of RNA export), it is widely accepted that the 
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majority of nuclear-cyctoplasmic transport of large molecules fufill the energetic 
requirements for transport via RanGTP hydrolysis. A diagram of Ran-GTP 
recycling and how it intersects with karyopherin-mediated nuclear transport is 
shown in Figure 8b. 
III. Nuclear import of mammalian RNA and DNA viruses 
All DNA viruses and many RNA viruses that infect mammalian cells must 
localize their genomes to the nucleus in order to establish a productive infection. 
HIV-1, the virus that is the subject of this thesis, is no different in this regard-
Therefore, in order to provide a context for the studies on HIV-l nuclear import 
described herein, a brief review of known mechanisms of nuclear import for 
several other viruses is provided below. 
Adenoviruses nuclear import 
The Adenovirus family of viruses are non-enveloped DNA viruses with 
characteristic isometric capsids of 60-90 nm in diameter and a linear double-
stranded DNA genome. These complex and functionally sophisticated viruses 
generally encode 11-15 different structural proteins that carryout the various 
duties required to establish persistent infection of target cells [reviewed in [99]]. 
Virion proteins include receptor-binding fibers extending from specialized 
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penton base complexes at the vertices of the icosahedral cores, and several D N A 
binding proteins such as the covalently bound p55 terminal protein at the 5' ends 
of the viral DNA [100-103]. 
After binding to cell surface CAR receptors, these viruses are internalized 
by receptor-mediated endocytosis [104]. Following endocytosis, they penetrate 
the endosomes by inducing acid-enhanced lysis of the endosomal-limiting 
membrane, and are then released into the cytoplasm [105]. The viruses are then 
transported through the cytosol to the nucleus where a large fraction bind to the 
nuclear pore complexes that adorn the nuclear membrane [106]. During nuclear 
transport, adenoviruses particles use microtubules and microtubule-dependent 
motors [107]. 
As the adenovirus particles migrate from the endosomes to the NPC, they 
undergo a series of programmed steps that appear to weaken the integrity of the 
sturdy viral capsid, allowing it to release its precious cargo of viral genetic 
information only once it has localized to the nuclear pore. The molecular 
alterations are triggered by receptor interactions, exposure to acidic pH, re-entry 
into a reducing milieu, and finally by interactions with the NPC [reviewed in 
[108]]. As fibers are stripped from the incoming viral particle once it emerges 
from the endosome, capsid stabilizing proteins dissociate from the viral core, and 
a protein that connects the DNA to the inside capsid's wall, protein IV, is 
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digested by a viral cysteine protease called p23 [109,110]. Once the stripped 
adenovirus particle reaches the NPC it encounters factors that trigger the final 
stages of particle dissociation. The FG nucleoporin Nup214/CAN is the docking 
site for adenoviral particles at the NPC, and unlike some other viruses, nuclear 
transport of the Ad2 virion presumably occurs in a karyopherin-independent 
manner [111]. By directly targeting a constituent of the NPC, in this case the 
filatmentous Nup214/CAN protein present on the cytoplasmic side of the NPC, 
the adenovirus particle ensures robust and rapid nuclear localization of its 
genome. Adenovirus has taken nuclear import a step further, and it appears that 
nuclear localization of the viral genome is a key regulatory step in the viral life 
cycle rather than a mundane requirement. This regulation is manifested in the 
binding of histone HI to the Nup214/CAN docked adenovirus particle, which 
allows the viral DNA to be shuttle through the nuclear pore via the same 
karyopherin-dependent mechanisms that histones use during normal cellular 
metabolism [111]. 
Of the DNA-binding proteins encoded by adenovirus, protein VII is 
thought to have a histone-like DNA-condensing function. It enters the nucleus at 
the same time as the DNA, and it is possible histone HI and protein VII act in 
concert to thread the DNA through the pore as a nucleoprotein complex [111, 
112]. The terminal protein p55 covalently associated with the 5' end of each Ad 
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D N A strand also enter the nucleus and play an important role in anchoring the 
viral DNA to the nuclear matrix [113]. Another Ad DNA binding protein, protein 
V, does not seem to enter with the DNA and its function during viral nuclear 
import remains unknown [108]. A small amount of the hexon protein from the 
incoming virus also finds its way into the nucleus, but this probably occurs 
independently of nuclear import of the viral DNA. While a precise role in the 
viral life cycle has not been assigned to all of the proteins encoded by 
adenovirus, the mechanism of Ad nuclear-cytoplasmic transport is one of the 
most clarified for mammalian viruses. 
Hepatitis B virus nuclear import 
The hepatitis B virus (HBV) is a prototype member of the family 
hepadnaviridae. It is enveloped, and has an icosahedral capsid core 32 nm in 
diameter. The protein shell is composed of 240 copies of a single protein, called 
the core protein, and expression of this protein alone is sufficient for the 
formation of a core particle [114]. Hepadnaviruses have a DNA genome, but 
because they replicate via an RNA intermediate, they require reverse 
transcription [115]. HBV and other hepadnaviruses enter the cell via receptor 
mediated endocytosis [116-118] and gain access to the cytosol via membrane 
fusion in endosomes [116]. The viral DNA is then transported to the nucleus 
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where the R N A template for reverse transcription (the pregenome) is synthesized 
by cellular RNA polymerase II [119]. After export to the cytoplasm, this viral 
RNA is used as a template for translation of the core protein and polymerase 
(polymerase or "P" protein), and it is also packaged into progeny core particles 
[120]. The RNA is reverse transcribed by the trapped P protein to the partially 
double-stranded DNA, and the polymerase remains covalently linked to the 
minus strand [121]. 
As the viral DNA in the incoming HBV virion is not intrinsically 
karyophilic [122], one or more of the structural proteins of the core must be 
responsible for mediating nuclear import of the HBV genome. The core protein is 
the leading candidate as a facilitator of viral nuclear import. The most 
compelling evidence that the core protein is essential to HBV nuclear import 
comes from studies with bacterially-expressed core particles that contain the core 
protein but no other components of the virus [123]. In an in vitro assay using 
digitonin-permeabilized human hepatoma HuH-7cells, these HBV cores bind 
specifically to the NPCs [123,124]. NPC binding was inhibited by wheat germ 
agglutinin, by anti-nuclear pore complex antibodies, and by peptides 
corresponding either to classical nuclear localization signals (NLS) or to COOH-
terminal sequences of the core protein [123]. Binding was dependent on the 
classical soluble nuclear transport receptors karyopherin a and |3. Nuclear 
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localization only occurred when the core protein was phosphorylated, suggesting 
that phosphorylation is required to induce the exposure of a cryptic NLS in the 
C-terminus of the HBV core protein that allows the virion to bind karyopherins 
and traverse the NPC by co-opting classical cellular nuclear import pathways 
[123,124]. Indeed, the C-terminus of the HBV core protein contains five potential 
Ser/Thr phosphorylation sites, and this arginine-rich stretch of sequence (amino 
acids 145-183 in HBV) has homology to classical basic nuclear localization 
signals [123,125,126]. 
The HBV NLS sequence overlaps with the RNA packaging domain (amino 
acids 141-164), as well as with a region that supports plus-strand DNA synthesis 
during genome maturation [127,128]. Prior to core maturation, these C-terminal 
sequences are present inside the central cavity of the core [126]. However, to 
become functional NLSs, they must be somehow exposed at the outer surface of 
the core. Perhaps core protein phosphorylation induces a conformational change 
that exposes these peptides on the outer surface of the virion where they can 
serve as substrates for karyopherin-mediated nuclear import. Cryoelectron 
microscopy studies show large holes in the capsid wall between individual core 
proteins [114]. These openings could allow the NLS peptides to poke out to the 
virion surface, where they can have access to the nuclear transport receptors 
(kapcx/ P) in the cytosol, without major changes in overall core architecture. 
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Whether or not significant viral core disassembly is necessary for H B V virion 
nuclear import (as is seen in the case of adenovirus nuclear import) is uncertain. 
However, the recent report from Rabe et al. suggests that HBV capsids were 
imported in intact form through the nuclear pore and localized to the interior of 
the NPC at the nuclear basket [124]. Import depended on phosphorylation of the 
capsid protein and was mediated by the cellular transport receptors karyopherin-
(X and -3- However, the uncoating reaction was independent of RanGTP binding, 
and occurs through a mechanism different than the one normally used to 
dissociate karyopherin-imported cargo in the nucleus [124]. Hepadnavirses are 
unusual in that a fraction of the cores do not leave the cell in the form of progeny 
virus but deliver their DNA directly into the nucleus of the host cell in which 
they have assembled. This is apparently required to replicate the viral DNA in 
the nucleus, which eventually reaches 20-50 copies per cell, and may be 
responsible for sustaining a level of latency in infected cells [115]. 
Influenza nuclear import 
Influenza viruses are enveloped animal viruses with a segmented, 
negative-sense RNA genome [129]. Individual influenza virions are typically 80 
-120 nm in diameter and often appear filamentous, especially when taken from 
fresh isolates [129]. They have eight distinct RNA molecules (viral chromosomes) 
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individually packaged into viral ribonucleoprotein complexes (vRNPs) that 
contain multiple copies of nucleoprotein (NP) and a single copy of a 
heterotrimeric polymerase. NP forms a proteinaceous core around which the 
RNA is wound in a helix [130]. The unwound length of the individual vRNPs 
varies from 20 to 80 nm depending on the size of the RNA [131]. However, the 
diameter of the rod-shaped vRNP particles is constant (between 10 and 20 nm) 
and they are small enough to overcome the size exclusion limit (~25 nm) of the 
nuclear pore and passively diffuse through the NPC. Indeed, current evidence 
suggests that incoming influenza vRNPs enter the nucleus in intact form through 
the NPCs [132], reminiscent of HBV nuclear import of its mostly intact viral 
particle. The NP and the viral polymerase accompany the RNA into the nucleus 
where they are required for transcription and replication [131]. 
Prior to nuclear import of vRNPs, these sub-viral structures must undergo 
two distinct low-pH-induced changes. First, an acid-induced conformational 
change in HA is required to trigger fusion and escape of the vRNPs into the 
cytoplasm [133] . Acidification has also been shown to induce an irreversible 
change in Ml, resulting in its dissociation from vRNPs [134,135]. The dissociated 
vRNPs are thus delivered to the cytosolic compartment from which they rapidly 
and efficiently move into the nucleus via the NPCs. Similar to what is seen 
during adenovirus import, dissociation of the influenza sub-viral complexes is a 
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key regulatory event in its virus life cycle. It has been shown that the antiviral 
drug amantadine, which blocks the M2 ion channel, thereby preventing 
endosomal acidification and viral uncoating, also abrogates nuclear import of the 
vRNPs [136-138]. 
While all of the known protein components of the vRNPs carry some type 
of NLS (as they must undergo transport to the nucleus after synthesis in infected 
cells), responsibility for nuclear transport of the influenza genome appear to fall 
on the NP protein [139]. NP is thought to mediate influenza nuclear import via 
classical basic-type NLS and interaction with the heterodimeric karyopherina/ (3 
molecules [139]. NP can also mediate the import of RNA with which it is 
complexed, implying that the NLS does not overlap with the RNA interaction 
domain. The import of the NP proteins alone was originally shown to depend on 
a basic-type NLS close to its N terminus [140,141], but it is probable that this N-
terminal NLS is dispensable for the process of viral genome nuclear import, as it 
is not conserved in other orthomyxovirus subtypes [142] . 
Unlike adenovirus particles, there is no evidence that influenza vRNP transport 
along any cytoskeletal elements once they have been released from endosomes 
[143,144]. 
Figure 9 summarizes the various routes of nuclear entry that are 
employed by adenovirus, hepatitis B virus, and HIV, which is the subject of this 
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thesis. All infectious viruses that rely on the nucleus as a site for their replication 
are presented with the challenge of passing through the nuclear pore complex 
(NPC) which tightly regulates molecular traffic into and out of the nucleus. 
Consistent with their roles as obligate intracellular parasites, many viruses have 
adapted to use the same machinery that the host cell utilizes for macromolecular 
transport through the NPC. Thus, the capsid proteins of several viruses, 
including those adenoviruses and hepadnaviruses like HBV, have evolved to 
contain NLS sequences that allow them to interact with soluble nuclear transport 
receptors like the karyopherins in order to deliver their genetic information to 
the nucleus. Notably, many such viruses undergo significant molecular 
alterations (i.e. decapsidation, stripping, acidic-induced structural changes) 
before they are capable of performing nuclear import. Lentiviruses like the 
human immunodeficiency virus (HIV) are no different in this regard, as a 
significant amount of rearrangement of the viral core constituents occurs as 
virions enter the target cell cytoplasm ande pre-integration complexes (PICs) are 
assembled. This thesis describes the potential role of one of the viral proteins 
that is present throughout the transmogrification of the incoming HIV viral 
particle, namely the HIV integrase, in facilitating the active nuclear transport of 
the reverse transcribed viral genome into the nucleus. 
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Figure 9. Mechanisms of D N A and R N A virus nuclear translocation. The proposed 
mechanisms for nuclear import for HIV-1, Adenovirus type-2 (Ad2), and Hepatitis B 
virus (HBV) are shown. A) HIV-1 nuclear import follows viral fusion/ entry and reverse 
transcription and precedes the step of proviral D N A integration in the nucleus. It is 
unclear whether HIV-1 utilizes classical nuclear import receptors such as karyopherin-
alpha and karyopherin-beta, and the precise mechanism of HIV-1 nuclear import is 
unknown. B) Ad2 nuclear import follows viral endocytosis/endosomal escape and 
relies upon a combination of host cell factors (karyopherin-alpha, karyopherin-beta, 
histone HI, and heat shock protein 70, all bound to the NPC via Nup214/CAN) to 
facilitate the breakdown of its capsid at the NPC, allowing the viral D N A to be injected 
through the nuclear pore and into the nucleus. C) HBV nuclear import occurs after the 
virus enters the cell by endocytosis and escapes the endocytic vesicle via a pH-
independent mechanism resulting in their release into the cytosol. Once in the cytosol, 
HBV virions bind karyopherin-alpha/karyopherin-beta heterodimers, traffic to the 
nucleus, and disassemble at the N P C to release the covalently closed circular viral D N A 
into the nucleus where it is transcribed into viral RNA, exported, and then reverse 
transcribed to H B V viral D N A in the cytosol. 
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This work also describes the identification of certain endogenous host cell 
factors (Lvl/TRIM5-CX) that can bind to incoming HIV and SIV virions, 
preventing them from completing reverse transcription and presumably 
abrogating their ability to localize to the nucleus in non-permissive primate cells. 
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chaptfr g. post-Entry restrictions to HIV-1 replication 
/. Species-specific restriction of lentiviral infections 
Many lentiviruses that infect humans and non-human primates exhibit a 
highly restricted species tropism. HIV-1, for example, is unable to replicate in 
cells derived from several nonhuman primates, including rhesus macaques, the 
most prominent monkey species used in animal models of AIDS [145] . 
Therefore, it would be of great scientific interest to those seeking to develop 
better animals models to study HIV-1 to determine the precise step of the viral 
life cycle at which replication is blocked in such non-permissive primate cells. It 
had previously been demonstrated that the block to HIV-1 replication in 
macaques occurs primarily during the early steps of the viral life cycle, such that 
reverse transcription does not proceed to completion [146,147]. However, the 
exact point in the viral life cycle where this species-specific restriction was 
manifest remained unknown. Indeed, the virus could have been inhibited at any 
of the steps that precede reverse transcription, such as envelope/receptor 
binding, viral membrane fusion/entry, or during the process of viral capsid 
uncoating. 
Observation of the SHIV rhesus macaque animal model, where a simian 
immunodeficiency viruses from macaques (SIVmac) is engineered to contain 
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envelope genes from HIV-1, reveals that such hybrid viruses can replicate in 
these animals [148]. Therefore, inefficient HIV-1 replication in this non-
permissive species cannot be explained entirely by envelope-receptor 
incongruities [149-151]. While some portion of the post-entry restriction of HIV-1 
in primates may be due to surface receptor-envelope incompatibility [152], 
certain primate cells display dramatic differences in their ability to support the 
early steps of the HIV-1 and SIV life cycles (even when pseudotyped with viral 
envelopes that have broad cellular tropism, such as the vesticular stomatitis virus 
glycoprotein (VSVg)) that cannot be fully explained by the differences in 
receptor-envelope binding [149,153]. Indeed, the existence of cellular factor(s) 
within the intracellular milieu that restricts HIV and SIV infection at a post-entry, 
pre-integration step in non-permissive cells may provide a plausible explanation 
to reconcile these observations. 
In mice, an example of such a host cell retrovirus-inhibiting factor is found 
in the case of the Friend virus susceptibility factor 1 (Fvl), a mouse gene product 
that can specifically block certain strains of the murine leukemia virus (MLV) 
[154,155]. The Fvl protein is derived from an ancient endogenous mouse 
retroviral gag gene, and disables incoming virions by binding to the MLV capsid 
(CA) immediately following entry into the cytoplasm, thereby preventing the 
virus from progressing through the remainder of the early steps in its replicative 
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cycle. This phenomenon, often referred to as the "Fvl phenotype" is saturable, 
and the addition of high levels of incoming virions (infection at very high MOI) 
can overcome the resistance to infection in non-permissive cells [156,157]. 
Interestingly, this Fvl phenotype is also observed in certain human cells lines 
that are non-permissive for MLV infection and is caused by a genetically 
unrelated factor called Refl [158,159]. 
In the Fvl phenotype of MLV, a single-amino-acid residue in the CA 
protein of the incoming virion determines the N- or B-cell tropism of the virus. B-
tropic MLV efficiently infects BALB/c cells but has only limited ability to 
replicate in NIH-3T3 cells, showing about a 100-fold lower titer. The opposite is 
true for N-tropic virus. The particular Fvl locus in the host determines whether a 
cell will be of the B- or N-type. The protein product of Fvl gene is presumed to 
interact with CA in the infecting virus, in a manner that is affected by this single 
amino acid change in the virion. While the Fvl gene has recently been cloned 
[158], its precise mechanism of action remains to be elucidated. However, it is 
known that the MLV CA protein is a component of the viral preintegration 
complex (PIC) in newly infected cells [160], reinforcing the proposed mechanism 
of how the mutations in MLV CA can block downstream events in the viral life 
cycle such as the completion of reverse transcription and nuclear import. The 
importance of the retroviral CA protein to determining the viral tropism is 
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underscored by the observation of cyclophilin A binding to the C A of HIV-1 
[161]. Treatment of virus-producing cells with cyclosporine, a drug that blocks 
cyclophilin A binding to CA and prevents its incorporation into budding virions, 
results in non-infectious virus that is blocked at an early step of the viral life cycle 
[162,163]. Cyclophilin A binds to a loop in CA containing proline 90 in an 
unusual trans-conformation [162]. How this binding affects virion infectivity is 
unknown, but there may be a causal relationship between cyclophilin A binding 
to CA and the activity of a soluble factor that blocks lentivirus infection. Others 
suggest that the biological function of cyclophilin A binding to CA might be to 
destabilize the shell of CA proteins, thereby facilitating core disassembly during 
uncoating and allowing the infecting virion to proceed smoothly through the 
remainder of its replication cycle [164]. 
Might there be a host cell factor that demonstrates a similar virus-
restricting phenotype in target cells for simian and human immunodeficiency 
viruses? Our recent studies have indicated that there does exist in certain 
primate cells a saturable inhibitor of primate lentiviruses, which we have termed 
Lvl (Lentivirus susceptibility factor 1), that blocks HIV and SIV replication at an 
early step of the virus life cycle in non-permissive cells [149]. Recently, screening 
of a rhesus monkey cDNA library has identified tripartite interaction motif 5 
-alpha (TRIM5-CX) as a factor that confers resistance to HIV-1 infection [165]. 
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Subsequent experiments have revealed that Lvl, Ref 1, and TRIM5-0C are most 
likely the same molecule, as expression of TRIM5-CX confers resistance to 
lentivirus infection to otherwise permissive cell types [166]. The work presented 
in this thesis provided the first proof that Lvl/ TRIM5-CX restriction occurs soon 
after the virus enters the infected cell, during the earliest steps of reverse 
transcription. 
II. Lv-l/TRIM5-a restriction occurs at the step of early reverse transcription 
A schematic diagram of the real time PCR assays that were developed to 
measure the various viral DNA intermediates (early and late reverse transcripts 
and 2-LTR circles) is shown in Figure 10. A more detailed description of these 
assays, including the locations of PCR primers and molecular beacons can be 
found in Chapter 6 Materials and Methods. In order to reduce the possibility of 
that contaminant DNA from the media used to make the viral stocks (i.e. leftover 
DNA from HEK 293T cell transfections) might confound our measurements of 
the viral DNA intermediates (specifically reverse transcription products) from 
infected cells, we developed a sensitive real time PCR assay to monitor the 
presence of this DNA species in our samples [Figure 10]. 
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Figure 10. Description of Real Time PCR assays. Schematic diagrams depict the real 
time PCR assays used to measure various viral D N A intermediates during HTV 
infection. A) The Early RT primer set amplifies a small stretch of viral D N A preceding 
the primer binding site (PBS) and measures "strong stop" reverse transcripts that occur 
before the first template strand switch. The Late RT assay uses a reverse primer that 
anneals downstream of the PBS, giving an estimate of the full length reverse transcribed 
viral DNA. The 2-LTR circle assays utilizes a primer set and beacon that spans the LTR 
"junction" following the end-joining ligation reaction that occurs once the viral D N A is 
in the nucleus. A "contamination" control PCR assay with one primer specific for the 
plasmid D N A "backbone" of R73 and other specific for a region in the 5'LTR allows the 
accurate quantification of the amount of viral D N A carried over from the transfection 
used to make the viral stocks. B) An example of a standard curve generated using a 2-
LTR circle plasmid as the template in this assay, starting with one million copies per 
nanogram of input D N A and 10-fold serially diluted to 10 copies per nanogram. 
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Using this assay, w e were able to detect small amounts of contaminant D N A 
from the viral stocks, but the level of this DNA was on average 2-3 orders of 
magnitude below the level of reverse transcripts measured, and could be further 
reduced by addition of increasing concentrations of Dnase I enzyme to the virus 
stocks prior to infection, as well as by increased washing of the cells after 
infection. 
In order to determine the step of the viral life cycle at which the Lvl 
phenoytpe is first manifest, we used the above real time PCR assays to monitor 
the early events in the viral life cycle in various primate cells. We first inoculated 
several primate cell lines with increasing amounts of VSV-G-pseudotyped HIV-1 
and STVmac reporter viruses. Large differences exist in the susceptibility of some 
of the cell lines to HIV-1 versus SlVmac infection at low multiplicity of infection 
(MOI= 1). Specifically, whereas the human cell line HeLa was approximately 
equivalently infected by HIV/GFP and SIV/GFP, Rhesus monkey (Rh.F) and 
Owl monkey (OMK) cells were infected at an almost 100-fold greater frequency 
by SIV/GFP than by HIV/GFP. In contrast, the squirrel monkey cell line, Pindak, 
exhibited precisely the opposite phenotype. The African green monkey (CV-1) 
cell line was almost equivalently infected by each of the viruses, although both 
appeared less infectious on CV-1 cells at low MOI as compared with HeLa cells. 
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Accordingly, w e then infected HeLa, O M K , and Rh.F cells with various 
doses of HIV GFP beginning with an MOI of 1000 with four 10-fold serial 
dilutions dilution until an MOI of 0.1 and then measured the accumulation of 
viral DNA intermediates at each dose. Analogous to the result seen with GFP 
expression measured by fluorescence activated cell sorting (FACS) analysis, 
OMK and Rh.F cells produced dramatically less reverse transcribed DNA 
following HIV GFP infection when compared to permissive HeLa cells [Figure 
11a]. The dramatic species-specific restriction conferred by Lvl / TRIM5-(X is 
even more clearly evident when one looks at the step of late reverse transcription 
[Figure lib] or at the viral 2-LTR circles which form following nuclear import 
(not shown). Indeed, 2-LTR circles were only detected in the permissive HeLa 
cells (72 hours post-infection), and no circles were evident from the non-
permissive Rh.F and OMK cell infections. This reinforces the assertion that Lvl/ 
TRIM5-a restriction truly occurs at a step that is prior to nuclear entry, and may 
point to a temporal association between reverse transcription and nuclear 
import. For example, Lvl/TRIM5-a binding to capsids would not only prevent 
the conformational changes necessary to form active reverse transcription 
complexes (and thus block reverse transcription), but would also prevent the 
formation of pre-integration complexes competent for nuclear import. While the 
absence of 2-LTR circle intermediates in the non-permissive HIV infected cells 
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suggests a defect in nuclear import accompanies the block to reverse 
transcription, future studies that seek to directly visualize Lvl/TRIM5-cx bound 
HIV cores will be needed to confirm this assumption. 
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Figure 11a. Titration of VSV-HIV GFP on non-permissive cells reveals Lvl/TRIM5-
alpha restriction is blocked at the step of early and late RT. Reduced accumulation of 
HIV-1 cDNA in nonpermissive primate cells is evident at low MOI. A) HeLa, Rh.F, and 
O M K cells were inoculated with varying amounts of VSV-G-pseudotyped HIVGFP and 
total D N A was isolated and reverse transcripts measured by real-time PCR 48 h later. 
Alternatively, (B) cells were inoculated with 25 ng (MOI ~0.1) of HIV-GFP, and reverse 
transcripts w e r e m e a s u r e d at the indicated times after infection [62]. D a t a are 
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Figure lib. Late reverse transcription is impaired in non-permissive primate cells. 
HeLa, O M K , and Rh.F cells were inoculated with 25 ng of HIV-GFP as above and total 
D N A was isolated 48 hours after infection and subjected to real time PCR analysis of 
completed late reverse transcripts. The inhibitory effect of Lvl/TRIM5-alpha produces a 
dramatic reduction in late reverse transcription in non-permissive O M K and Rh.F cells, 
which coincides with a lack of viral gene expression (GFP) as measured by FACS 
analysis, and a reduction in 2LTR circle copies. Data are representative of three 
independent experiments. 
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Chapter a. Nuclear Translocation of HIV-1 
Defining the role of HIV-1 integrase during viral nuclear import 
Integrase has been mutagenized extensively in the context of numerous 
functional studies, but a systematic set of mutants has not yet been employed to 
localize determinants regulating its nuclear import. In previous studies [167] the 
integrase coding region was fused to the carboxyl-terminus of enhanced green 
fluorescent protein (EGFP), and the construct was transfected into HEK 293T 
cells. As expected, the 60 kD chimeric protein (EGFP-IN) localized 
predominantly to the nucleus in regions distinct from the nucleolus. An extensive 
set of charged-cluster-to-alanine mutations and carboxyl-terminal deletions were 
then introduced into the integrase portion of the EGFP-IN construct, and their 
effects on its sub-cellular localization determined. Alanine substitutions within 
the carboxyl-terminus of IN spanning residues 236-40 and 262-266, resulted in 
complete exclusion of EGFP-IN from the nucleus [167]. 
Mutagenesis of native integrase or transfer of the integrase carboxyl-
terminal domain to otherwise cytoplasmic proteins [shown in Figure 12] 
confirms the existence of a potent NLS in this region. Remarkably, the charged 
residues do not by themselves confer NLS activity, as appending small 10-20 mer 
peptides corresponding to these regions within IN were not able to redirect 
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excluded eGFP-MBP fusion proteins to the nucleus [167]. Therefore it appears 
that the NLS activity of IN requires the structural integrity of a three dimensional 
SH3-like fold previously determined by others to exist in the carboxyl-terminal 
domain of integrase [168]. In addition, it is important to note that alignment of 
the amino acid sequences from over five hundred different primary isolates of 
HIV, spanning several of the known viral quasispecies including clades A, B, C, 
D, E, and G shows that this region of integrase is highly conserved, especially at 
the amino acid residues that we have identified as being critical for NLS activity 
[Figure 13]. This may underscore the importance of this region to the viral life 
cycle, specifically the residues critical to NLS function, as all viral subtypes 
would need to conserve this IN NLS region in order to interact with common 
cellular nuclear import machinery allowing the PIC to make it to the nucleus to 
become stably integrated into host chromosomal DNA. Indeed, the 
evoluntionary importance of this structure to the virus could be significant, as the 
residues that define the NLS element are highly conserved in multiple primate 
and non-primate lentiviridae. The conservation is complete in placement and 
sequence at the specified positions within the integrase protein including 
residues K236, R262, R263, K266, and partially at position K240. 
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Figure 12. The C-terminal domain of HIV-1 integrase encodes an NLS activity that 
localizes large, otherwise cytoplasmic proteins to the nucleus. H E K 293T cells were 
transfected with D N A constructs encoding a fusion protein of enhanced green 
fluorescent protein (eGFP) and maltose binding protein (MBP) of 75 kiloDaltons, in 
excess of the nuclear pore exclusion limit (50-60 kD). The addition of the last 76 amino 
acids of HIV-1 integrase (the entire C-terminal domain) to this eGFP-MBP fusion 
resulted in the nuclear localization of this otherwise cytoplasmic protein. Inclusion of a 
double (K236/240A) or triple (R262/3/6) mutation in the appended IN C-terminus 
resulted in nuclear exclusion. A) control eGFP-MBP alone, (B) eGFP-MBP-IN-WT, (C) 
eGFP-MBP-IN-K236/240A, (D) eGFP-MBP-IN-R262/3/6A. All cells are shown at 63X 
magnification and each panel is representative of 50-100 eGFP-positive cells per field, 
four fields per slide, and representative of three separate experiments. 
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For the non-primate lentiviridae EIAV, FIV, BIV and Visna virus, this 
overall pattern of basic residue conservation within the integrase C-terminus is 
noticeable as well. Generally, clusters of basic residues are roughly 25-30 amino 
acids apart with hydrophobic residues involved in maintaining both the SH3 
monomeric structure and the SH3:SH3 dimer interface notably preserved. 
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Figure 13. Conservation of Amino Acid Sequence in the C-terminal domain of HIV-1 
Integrase. Five hundred and twenty HIV isolates across clades A, B, C, D, E and G were 
aligned in the pol gene region corresponding to the last 50 amino acids of the integrase 
protein. Overall, with the exception of 3 residues that displayed great variation 
(indicated by an *), there is a high degree of sequence conservation in this region, 
especially at the residues that w e have identified as relevant to viral nuclear import (red 
arrows). 
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I. The carboxyl terminus of HIV-1 integrase specifies a transferable nuclear localization 
signal (IN NLS) that functions in primary cells 
As mentioned previously, introducing mutations in the integrase region of 
pol can often have pleiotropic effects on essential viral activities other than 
nuclear import, such as PIC assembly or reverse transcription. As the integrase 
SH3 domain has been shown to bind DNA non-specifically in vitro [169-172], and 
one of the set of mutations that we have identified as critical for NLS activity 
overlaps a residue (Lys at position 264) that is important for this non-specific 
DNA binding, we sought to perform experiments to preclude the possibility that 
the NLS we have identified simply coordinates host chromosomal DNA binding. 
If this were the case, then the IN C-terminus could mimic the activity of a bona 
fide nuclear localization signal in actively dividing cell lines (such as HEK 293T 
cells) by providing, for example, a nuclear retention function allowing the eGFP-
IN fusion proteins to latch onto euchromatin nonspecifically as the cell divides. 
Figure 14 shows that the integrase NLS element is capable of providing nuclear 
import activity to otherwise cytoplasmic eGFP-MBP fusion proteins even in non-
dividing cells of primary origin (immature dendritic cells and CD4+ T cells); 
evidence that the integrase NLS is operational for import when the nuclear 
membrane remains intact and when no transient access to chromosomal DNA 
during cell division is available. The process of nucleofection that was used to 
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introduce the eGFP-MBP-IN plasmid D N A s into non-dividing D C and T cells 
produces transient porosity of the cell's plasma membrane but the nuclear 
membrane remains intact [173], and, while considerable cell death is evident in 
the samples following this procedure, there is no evidence of cell division as 
measured by CSFE staining and FACS anaylsis of samples after nucleofection 
(not shown). Therefore, its is unlikely that the apparent karyophilic activity 
provided by the HIV IN C-terminus is simply an artifact of experiments 
performed in dividing cells, which highlights the potential importance of this 
domain of integrase as a facilitator of viral nuclear import during natural 
infection in vivo. 
II. Kinetics of HIV IN NLS mutant viruses in dividing and non-dividing cells 
Reconstruction of these integrase NLS mutants into an otherwise 
infectious HIV-1 proviral clone (R7-3 with a macrophage tropic (Yu2) or T cell 
tropic (HXB-2) envelope) resulted in a replication-defective phenotype in all cell 
types tested. Figure 15 shows the results of infection or the T lymphoblastoid cell 
line CEM-SS cells, primary human monocyte-derived macrophages (MDM), and 
primary CD8-depleted PHA-activated peripheral blood lymphocytes (PBLs) with 
either macrophage tropic or T cell tropic HIV variants containing mutations to 
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Figure 14. (Caption continued on page 67). 
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Figure 14. The C-terminal domain of HIV-1 integrase displays NLS activity in non-
dividing dendritic cells and CD4+ T cells. Primary human dendritic cells and CD4+ T 
cells were transfected with plasmid D N A encoding various eGFP-MBP-Integrase C-
terminal fusion proteins using the A M A X A Nucleofection procedure as per the 
manufacturer's protocol. At 12 hours post-nucleofection, cells were washed, fixed with 
4% PFA and mounted onto microscope slides with medium containing DAPI to stain the 
nuclear D N A (blue). Cells that were positive for eGFP expression (green), and therefore 
expressing the eGFP-MBP-Integrase fusion constructs, were visualized by confocal 
microscopy using a DeltaVision microscope. Constructs specifying eGFP conjugated to 
either the SV40 virus NLS or nucleoplasmin NLS were included as controls for nuclear 
import. A construct encoding the eGFP-MBP fusion protein alone (75 kD, too larger to 
passively diffuse through the NPC) was used as a control for nuclear exclusion. A) 
Addition of the C-terminal 76 amino acid polypeptide (residues 212-288) of HIV-1 
integrase confers an NLS activity to an otherwise cytoplasmic protein in primary human 
CD4+ T cells. B) The C-terminal HTV-1 Integrase NLS is also functional in non-dividing 
primary human dendritic cells. Mutation of the residues previously shown to affect HTV 
-1 nuclear import (K236/240A and R262/3/6A) in the context of this appended C-
terminal domain resulted in nuclear exclusion of the fusion protein. All cells are shown 
at 100X magnification and each panel is representative of 50-100 GFP positive cells per 
field, four fields per slide, and a minimum of three separate experiments. 
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the defined N L S regions K236/240A and R262/3/6A. Examining the 
infected cell supernatants for the presence of the viral p24 Gag antigen indicates 
that these mutations result in a non-productive infection when compared to 
cognate wild type viruses. Similarly, transfer of infected cell supernatants taken 
from each cell type after seven days in culture produced the same pattern of 
infection when added to fresh cultures of target cells that are permissive for HIV 
infection such as PHA-stimulated CD8-depleted PBLs. Thus, incorporation of 
this double (K236/240A) and triple (R262/3/6A) mutation into an otherwise 
infectious proviral molecular clone results in a virus that is replication-defective, 
presumably because viral nuclear import is unable to proceed to completion. 
III. Real time PCR analysis of viral DNA intermediates after infection with IN NLS 
mutant viruses 
In order to examine the effects of NLS mutants on specific early stages of 
the HIV life cycle, we developed a series of sensitive, stage-specific real-time 
PCR-based assays that quantitatively measure progression through reverse 
transcription and nuclear import. In agreement with other kinetic PCR assays 
[174], calibration of a typical spreading infection with wild-type virus exhibits a 
2- to 4- log increase over baseline for each of the viral DNA intermediates over 48 
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Figure 15. Replication kinetics of HIV IN NLS mutant viruses in dividing and non-
dividing cells. Non-dividing primary human monocyte-derived macrophages (MDM) 
and CD8-depleted peripheral lymphocytes (PBL) were infected with HTV molecular 
clones derived from the HXB2 strain (R7-3), containing our NLS mutations in the 
integrase region of the pol gene, and pseudotyped with either a T cell-tropic or M-tropic 
(Yu2) HTV envelope. After 6 hour initial incubation with virus, cells were washed and 
media was collected at the indicated time points A) M D M infected with wild type 
(WT) virus produced p24 consistent with a productive spreading infection while NLS 
mutant viruses did not (K236/240A=M1, R262/3/6A=M2, 260stop=M3). B) The NLS 
mutant viruses are replication defective in the CEM-SS lymphoblastoid cell line. C) 
CD8-depleted PBL do not support replication of the NLS mutant viruses, while W T 
virus readily replicates in these cells (media assayed at a single time point 8 days post 
infection in panel C). Data are representative of five separate experiments. 
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Notably, the copy number per cell equivalent of each stage-specific 
product is approximately 1-2 orders of magnitude less than the previous step, 
with early reverse transcripts the most abundant and 2-LTR circles the least, 
highlighting the relative inefficiency of the conversion of viral RNA into nuclear 
viral DNA species. 
Single-cycle infections with wild type and NLS-mutant R5 and X4 viruses 
were performed in CD8-depleted, activated primary lymphocytes and MDM, 
respectively. In all cases, the integrase strand-transfer inhibitor, L-731,988 [175], 
was added to the infections. This inhibitor has no effect on the nuclear 
localization of the enzyme or viral DNA accumulation in the nucleus but renders 
it catalytically inactive at the strand-transfer step [175]. Inclusion of the strand 
transfer inhibitor allowed a comparison of all viruses during a single round of 
infection. In addition, it increased the utility and accuracy of the 2-LTR circle 
assay as a marker for PIC nuclear import by eliminating potential variations in 
integration efficiency between the wild type and mutant viruses. This is 
important for avoiding confounding effects, since the frequency of viral 
integration is inversely correlated with the accumulation of the circular viral 
DNA species found in the nucleus [42,175]. 
Figure 16 shows that while wild type and integrase NLS-mutant viruses 
are able to complete the late stage of reverse transcription with equal efficiency, 
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all NLS-mutant viruses exhibit a severe defect in proviral nuclear import, as 
measured by 2-LTR circle formation in primary human MDM. The same pattern 
was observed in CD8-depleted PBL [Figure 17]. 
In order to ensure that the presence of a pharmacological integrase 
inhibitor did not confound our results by exerting possible pleiotropic effects, 
experiments were repeated in the absence of the drug. Here, MDM were infected 
with wild-type and NLS-mutant viruses containing an additional mutation, IN 
D116A, which by itself has no effect on nuclear localization of the integrase 
protein, reverse transcription, or transport of the viral genome into the nuclear 
compartment, but prevents integration and further progression through the viral 
life cycle [42]. Results using these viruses were the same as those obtained using 
the small molecule integrase inhibitor, with a specific and severe two-log defect 
evident at the level of 2-LTR circle formation. Thus, the functional integrase NLS 
described here is necessary and sufficient for efficient nuclear accumulation of 
the viral genome in cell types reflective of the natural target cells for HIV 
infection in vivo. 
To rule out any effects the amount of virus used to initiate an infection 
might have on the interpretation of our results, we determined the level of late 
reverse transcripts over a two-log range of X4 and R5 viral input concentrations 
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Figure 16. Real time P C R analysis of viral D N A intermediates in primary h u m a n 
macrophages following infection with H I V IN N L S viruses. Primary human 
macrophages were infected with macrophage-tropic HIV viruses containing the 
previously identified integrase N L S mutations K236/240A, R262/3/6A, and 260stop in 
the presence of the diketo integrase inhibitor L-731,988. After addition of viral stock, 
cells were washed with phosphate buffered saline, then fresh media was added and the 
infected macrophages were kept in culture with drug for total of 8 days. Total genomic 
D N A was isolated at 0, 6, 24, 48, 96, and 196 hours post infection and viral D N A 
intermediates for late reverse transcription (A) and 2-LTR circles (B) were quantified via 
real time PCR. With the exception of the 260stop truncation mutant, the IN N L S 
mutations displayed little or no defect in reverse transcription, while there was a marked 
decrease in 2-LTR circles compared to wild type virus (solid black circles), suggesting 
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Figure 17. Real time PCR analysis of viral D N A intermediates in primary human 
CD8-depleted PBL following infection with HIV IN NLS viruses. CD8-depleted, 
PHA-activated primary human peripheral blood lymphocytes (PBL) were infected with 
T cell-tropic HIV viruses containing the previously identified integrase NLS mutations 
K236/240A, R262/3/6A, and 260stop in the presence of the diketo integrase inhibitor L 
-731,988. After addition of viral stock, cells were washed with phosphate buffered 
saline, then fresh media was added and the infected PBLs were kept in culture with drug 
for total of 8 days. Total genomic D N A w a s isolated at 0, 6, 24, 48, 96, and 196 hours post 
infection and viral D N A intermediates for late reverse transcription (A) and 2-LTR 
circles (B) were quantified via real time P C R . With the exception of the 260stop 
truncation mutant, the IN N L S mutations displayed little or no defect in reverse 
transcription, while there w a s a marked decrease in 2-LTR circles compared to wild type 
virus (solid black circles), suggesting that these viruses are defective for nuclear import. 
Results are representative of three separate experiments. 
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For example, viral c D N A is unstable in infected cells, with incompletely 
synthesized genomes preferentially targeted for degradation [176]. Thus, total 
cellular DNA was isolated six hours after infection and the amount of late reverse 
transcripts produced was determined for cultures of CD8-depleted PBLs and 
MDM. The accumulation of late reverse transcription products in the integrase 
NLS mutant is identical to that of the wild-type virus over the range of doses 
tested (data not shown), suggesting that any potential dose-dependent effects of 
viral innoculum on our reverse transcription measurements are minimal, and 
would not confound the measurements of 2-LTR circle products that formed 
downstream of the completion of reverse transcription. 
Finally, to ensure that the role of integrase in viral nuclear import was 
independent of upstream events of the viral life cycle, we attempted to 
pharmacologically isolate and continuously monitor a single population of 
reverse transcripts for nuclear import. MDM were infected with either wild type 
or IN NLS mutant virus in the presence of the integrase strand transfer inhibitor 
L-731,988 as described above. Then, at 3 hours post-infection, the non-nucleoside 
reverse transcriptase inhibitor, UC-781 [177], was added to block further DNA 
synthesis, and the levels of reverse transcript and 2-LTR circle formation was 
monitored at various times post-addition by real-time PCR. Under these 
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conditions, both the production and stability of viral c D N A transcripts were 
identical in the wild type and mutant viral infections [Figure 18a]. However, 2-
LTR circle formation (presumably from the nuclear import-competent PIC that 
formed prior to the addition of the RT inhibitor) was dramatically reduced for 
the IN K236A/240A virus relative to the wild-type, indicating a specific and 
severe defect for nuclear import when this stage of the viral life cycle is 
pharmacologically uncoupled from upstream and downstream events by 
treatment with the RT inhibitor UC-781 [Figure 18b]. 
IV Preintegration complexes and purified proteins from IN NLS mutants are 
catalytically active in vitro 
In order to prove that our integrase NLS mutants were competent to 
perform the normal obligate catalyses of the enzyme, purified versions of both 
wild type and NLS mutant codon-optimized integrase proteins (IN MOD) were 
made (courtesy of the lab of Dr. Daria Hazuda, Merck). These purified IN 
proteins were analyzed using the Quick IN assay for strand transfer described 
previously by Hazuda et al. [175, 178-181]. The K236/240A mutant was nearly 
equivalent to wild type protein in its ability to perform the strand transfer 
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reaction, while both the R262/3/6A and 260stop mutant were impaired (45-50% 
of wild type activity) in this assay [Figure 19b (top panel)]. 
In addition, we developed a quantitative real time PCR based assay for 
quantifying integration of the viral genome into a small (186 base pair) target 
DNA. Cytosolic extracts containing active pre-integration complexes were made 
from macrophages infected with the wild type and NLS mutants, incubated with 
a defined amount of the small target DNA, phenohchloroform extracted and 
used as a template in our quantitative real time PCR assay for integration. 
Figure 19 describes the assay setup and shows the results of both sets of 
experiments with purified IN NLS mutant proteins or purified HIV PICs from 
the mutant NLS viruses. The K236/240A NLS mutant PICs showed no defect in 
their ability to integrate into target DNA compared to wild type PICs. However, 
a defect in integration activity was noticed for the R262/3/6A and 260 stop NLS 
mutants (50 and 75 percent, respectively) compared to wild type PICs. PIC from 
the D116A mutant, as well as PICs from cells infected with wild type virus and 
treated with 10 |JM of the strand-transfer inhibitor L-731,988 were included as 
controls and produced background levels of integration as expected. Thus, the 
results of these experiments suggest that all of the NLS mutants are competent to 
some degree to catalyze the strand transfer reaction. 
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Figure 18. Pharmacological isolation of viral D N A intermediates at the step of reverse 
transcription reveals RT-independent effect of IN NLS mutants on nuclear import in 
primary human macrophages. Primary human macrophages were infected with M-
tropic HTV containing the IN NLS mutations as well as the D116A active site mutation at 
a high M O I (10), then treated with a non-nucleoside reverse transcriptase inhibitor (UC 
-781) at 3 hours post-infection. Total genomic D N A was isolated at 0, 6,12, 24, 48, 96, 
and 196 hours post-UC-781 addition and viral D N A intermediates for early and late 
reverse transcription and 2-LTR circles were measured by real time PCR. Under 
conditions where reverse transcription is inhibited, a marked decrease in 2-LTR circles is 
apparent for the NLS mutants compared to wild type virus, suggesting that these 
mutants are specifically impaired for the step of viral nuclear import. Data is 
representative of two separate experiments. 
77 
In the case of the mutants that were compromised for this catalytic activity 
(the R262/3/6A and 260stop mutants), this may be due to a decrease in their 
ability to bind the target DNA substrate, as residues within this region of IN have 
been implicated in DNA binding [169, 170]. As the K236/240A mutant was 
nearly equivalent to wild type integrase activity in both assays, its effects on 
nuclear import are independent of its ability to perform the enzymes' normal 
catalytic functions in vitro. 
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Figure 19. Pre-integration complexes from IN NLS mutant viruses are catalytically 
active in vitro. In order to test the ability of the NLS mutant PICs to perform other 
obligate catalytic functions of integrase, we added cytosolic extracts from cells infected 
with wild type or NLS mutant viruses to a small 186 base pair target DNA. A) A 
schematic diagram of the PIC integration real time PCR assay set up is shown. A 
forward primer annealing to a defined stretch of sequence in the target D N A was paired 
with a reverse primer and molecular beacon specific for the 5' LTR allowing for 
quantitative measurement of an approximately 156 bp integration product. An example 
of a standard curve generated with a plasmid containing this integration product is 
shown. B) The Quick IN integration assay of purified IN proteins was performed and 
data is expressed as percentage of wild type activity per microgram of protein. PICs 
from W T and NLS mutant viruses were incubated with target D N A for 2 hours at 37 
degrees C, then integration products were phenol:chloroform extracted and quantified 
using the real time PCR assay described above. Both the R262/3/6A and 260stop 
mutants displayed decreased integration (50% and 30% of W T respectively), while the 
K236/240A mutant showed no integration defect. A D116A active site mutant, and wild 
type PICs treated with the integrase inhibitor L-731,988 were included as controls. 
Equivalent amounts of PICs (as measured by late RT products in the PIC preps) were 
added to 250 ng of target D N A in each reaction. The quick IN assay represents two 
independent experiments and the PIC integration experiment was repeated three times. 
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V. Digitonin-permeabilized macrophage nuclear import assay system reveals excluded 
phenotypes for IN NLS mutants 
The cloning and preparation of recombinant factors required for signal-
dependent nuclear transport has accelerated the study of intracellular trafficking. 
We have maintained collaboration with the laboratory of Dr. Gunter Blobel at 
Rockefeller University to facilitate our analysis of HIV-1 nuclear import and this 
interaction has been valuable given the remarkable and extensive set of 
conventional recombinant nuclear transport factors cloned and purified by this 
laboratory. To make use of this knowledge and the latest approaches to the study 
of intracellular trafficking, we have developed a semi-intact cellular based 
system centered on the selective soponification of the plasma membrane over 
that of the nuclear membrane. This system maintains the nucleus (and the 
nuclear membrane) structurally intact and in a state competent for signal-
dependent nuclear pore translocation. Digitonin permeabilization, followed by 
extensive washing with isotonic transport buffer, literally "flushes" the soluble 
factors required for nuclear import out of the cell's cytoplasmic compartment. 
Specific factors required for nuclear transport of a given protein cargo or complex 
can be studied in detail by the addition of these factors back into the cell from 
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fractionated cytosol preparations or, depending on their availability, from a 
specific combination of the recombinant factors and transport factors of interest. 
In this reconstituted import system, proteins with active nuclear localization 
signals can be found in the nucleus within as early as thirty minutes after 
addition to permeabilized cells and reach more than a thirty-fold increase in 
concentration into this compartment [182]. 
In our experiments we used primary human macrophages as the target 
cells for permeabilization, as this cell type is relevant to HIV infection in vivo. The 
digitonin-permeabilized macrophage cell system reproduces authentic nuclear 
protein import in that it requires a functional nuclear localization sequence, ATP 
and cytosol, is temperature dependent, and is inhibited by wheat germ 
agglutinin (WGA), a molecule that binds the nuclear pore and is a potent 
inhibitor of nuclear transport in vivo. The results obtained using purified IN 
proteins [Figure 20] containing our NLS mutations, as well as PICs from cells 
infected with the NLS mutant viruses [Figure 21], have reinforced our belief that 
the carboxyl-terminal domain of integrase is indispensable for viral nuclear 
import, as the nuclear excluded phenotype we observed in the previously 
described studies of eGFP-MBP fusion proteins containing the NLS mutations 
can be recapitulated in this ex vivo system. Digitionin-permeabilized 
macrophages were incubated with nuclear transport mixtures containing 
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purified proteins or PICs (cytosolic extracts from infected macrophages) for 2 
hours to allow nuclear import to occur, then cells were washed, fixed with 
paraformaldehyde (PFA), and immunohistochemically stained with monoclonal 
antibodies specific for the N-terminus of HIV integrase. Purified GST-GFP fusion 
proteins plus or minus the NLS peptide from nucleoplasmin (courtesy of Dr. 
Elias Coutavas, Rockefeller University) were subjected to the same conditions 
and visualized in cells in order to clearly define what a nuclear localized protein 
looks like inside of permeabilized macrophages. Other controls included 
immunostaining with non-specific IgG antibody as well as uninfected cell 
cytosol containing no PICs. In addition, the nuclear pore blocking compound, 
wheat-germ agglutinin (WGA), was included in some of the nuclear transport 
assays, in order to show that PIC nuclear import is indeed conducted through the 
NPC [shown in Figure 21]. 
VI. Vpr-GFP tagged IN NLS mutant viruses display decreased nuclear localization 
The labeling of HIV virions via incorporation of fluorescently-tagged Vpr 
molecules has previously been described [27,183]. In order to directly visualized 
the sub-cellular localization of our NLS mutant virions during a live ongoing 
infection, viral stocks of Vpr-GFP labeled virions containing these mutations in 
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Figure 20. Digitonin-permeabilized macrophage nuclear import assay system reveals 
excluded phenotypes for IN N L S mutant purified proteins. Primary human 
macrophages were grown on poly-L-lysine coated 1 2 m m round glass coverslips and 
permeabilized with digitonin (see Methods). Cells were washed with IX transport 
buffer to remove the cytosol, then a mixture containing xenopus oocyte cytoplasmic 
extract, ATP energy source, R A N , GTP, and lug of purified HIV integrase was added 
and cells were incubated at 37 degrees Celsius to allow nuclear import to occur. A) A 
diagram of the permeabilized cell system, followed by results of initial experiments 
using purified W T IN from the pNL4-3 strain of HIV detected with an anti-IN 
monoclonal antibody (mAb6G5) and a tyramide- FITC (green) kit. A GST-GFP fusion 
protein +/- the nucleoplasmin (NP) N L S was included as a control for nuclear import. 
B) Wild type (WT) and K236/ 240A mutant purified IN proteins from the HIV IIIB strain 
were added to transport reactions on permeabilized macrophages, and stained with 
m A b 6 G 5 followed by a tyramide-Cy3 detector. The K236/240A mutant displayed a 
nuclear exclusion phenotype when compared to W T (white arrows) similar to that seen 
in the eGFP-MBP fusion protein studies described previously. All cells were stained 
with DAPI to visualize the nuclear D N A (blue). Cells were visualized at 100X 
magnification on a DeltaVision microscope and each panel is representative of 30-50 
permeabilized stained cells per field, four fields per slide, and three independent 
experiments. 
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IN were made by co-transfection of these plasmids along with a plasmid 
encoding the Vpr-GFP fusion protein in HEK 293T cells. Primary human 
macrophages were seeded onto special Petri dishes (containing a single glass 
microscope slide embedded in the middle), and GFP-tagged virions were 
continuously visualized by live-cell imaging over a 16 hour period. Figure 22 
shows still photos of macrophages infected with macrophage-tropic (Yu2 env) 
wild type NLS (D116A mutant) and K236/240A NLS mutant viruses at 6 hours 
post infection. The wild type NLS viruses clearly demonstrate a propensity to 
congregate around the nucleus, a pattern which is evident as early as one hour 
post infection and characterized by circular configurations of GFP-labeled virions 
around the surface reminiscent of nuclear "rim staining" of nucleoporins like 
Nup358 (see Fig. 21). Meanwhile, the K236/240A mutant virions did not display 
the same pattern of nuclear localization in infected macrophages, with the 
majority of the particles appearing scattered throughout the cytosol. Close 
examination of time-lapse movies made from assembled images from the live-
cell infections [Figure 30, attached DVD] shows that, while many virions appear 
to move towards the nucleus in the wild type NLS cultures, the Vpr-GFP 
molecules never actually enter the nucleus per se, and the particles seem to 
remain attached to the nucleus on the cyctoplasmic side. 
84 













Figure 21. Digitonin-permeabilized macrophage nuclear import assay system reveals 
excluded phenotypes for IN NLS mutant pre-integration complexes. Three million 
macrophages were infected with a high MOI (100) of M-tropic HTV virus stock (wild 
type R73-Yu2 and IN K236/240A as well as R262/3/6A NLS mutants). Twelve hours 
following infection, a cytosolic extract was made from these infected cells and added to 
donor-matched digitonin-permeabilized human macrophages. Immuno-histochemical 
staining was performed using anti-integrase monoclonal antibodies (INT-2, iNT-4, 
mAb6G5) with a FITC-tyramide detector (green). Nuclear pores were stained with anti-
Nup358 polyclonal rabbit antibodies (C-288 from E. Coutavas) coupled to an anti-rabbit 
quantum dot 655 detector (red). Nuclei were stained with DAPI (blue) upon mounting. 
A) Wild type R73-Yu2 PICs. B) Wild type PICs + Wheat Germ Agglutinin (WGA), which 
blocks transport through nuclear pores. C) IN K236/240APICs. D) IN R262/3/6 PICs. 
Images were taken at 100X magnification, each one representative of 30-50 
permeabilized stained cells per field, four fields per slide, in four independent 
experiments. 
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This observation is consistent with previous reports of the karyophilic 
properties of the Vpr molecule itself [64, 184, 185], and the fact that the NLS 
mutant Vpr-GFP mutants remained in the cytosol suggests that the NLS activity 
in the integrase C-terminus may have hierarchical superiority over that conferred 
by Vpr or other constituents of the PIC. 
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Figure 22. Vpr-GFP tagged IN NLS mutants display decreased nuclear localization in 
primary human macrophages. Vpr-GFP tagged virions were produced by double 
transfection of 293 T cells with a plasmid encoding the Vpr-GFP fusion protein (T. Hope) 
and a plasmid specifying an M-tropic Vpr-deficient HIV molecular clone (R73-Yu2-
deltaVpr). Primary human macrophages were then infected with these Vpr-GFP viruses 
(+/- the IN K236/240A NLS mutation) at a high MOI, and cells were visualized at 6 
hours post infection. A) Representative cells (of 50-100 per slide) are shown for W T and 
IN K236/240A Vpr-GFP infections with the nuclear D N A stained with DAPI (blue). 
Individual PIC and PIC clusters are visible in green. B) Still photos from live-cell 
imaging of HIV infection of macrophages. The nuclei in each field are indicated with 
yellow arrows and GFP-tagged virions are shown in green. The D116A active site 
mutant showed a nuclear localized phenotype than the K236/240A mutant, reinforcing 
the importance of an intact IN C-terminus to nuclear import. Images are representative 
of 30-50 Vpr-GFP positive cells per field, four fields per slide, in two independent 
experiments. 
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Chapter a.. Stability and gene expression from unintegratep 
COVALENTLY-CLOSED CIRCULAR HIV-1 DNA 
When the human immunodeficiency virus infects target cells HIV 
integrase catalyzes the 3' processing and strand transfer reactions that are 
necessary for viral replication. However, HIV Integrase-mediated insertion of 
the proviral DNA into host chromosomal DNA is not absolute. It has been 
known for over a decade that circular forms of viral DNA accumulate within 
cells following infection with wild type HIV in vitro [186]. Yet, the role of these 
viral DNA circles in the life cycle of the human immunodeficiency virus has only 
recently begun to be elucidated. Thus, understanding the potential role that 
these viral DNA circles may play in supporting HIV infection and latency in 
various cellular compartments is of key importance. 
The accumulation of 1- and 2-LTR circles in monocyte-derived 
macrophages and T cell lines following HIV infection with wild type virus in 
vitro has been described [187]. Previous studies with integration-defective HIV 
molecular clones and more recent studies with first-generation diketo acid HIV 
integrase inhibitors have shown that 2-LTR circular forms of viral DNA 
preferentially accumulate in T cell lines during infection with a catalytic triad 
HIV integrase mutant virus or with wild type virus treated with HIV integrase 
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inhibitors [175]. These episomal circular viral D N A s are capable of limited tat 
and nef gene expression [41,187]. However, viral p24 gag gene expression from 
2-LTR circles has never been documented. Accordingly, infection with 
integration-defective catalytic triad mutant HIV molecular clones results in a 
single-cycle non-productive infection in vitro. 
During a productive HIV infection, antigen presenting cells including 
dendritic cells and macrophages process viral protein antigens and present them 
to T cells to initiate the antiviral immune response [reviewed in [188]]. 
However, the ability of viral proteins expressed from 2-LTR circles to stimulate 
antiviral immune responses has not been ascertained. A recent report by Bakri et 
al. describe the detection of 1- and 2-LTR circles in cultures of immature and 
mature dendritic cells [189]. However, prior to the data presented in this thesis, 
there have been no published accounts of long-term persistence or protein 
expression from LTR circles from integration defective HIV viruses or HIV 
vectors in myeloid-derived cells such as primary human macrophages or 
immature dendritic cells. 
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I. HIV-1 2-LTR circles are stable in primary human macrophages and immature dendritic 
cells 
Primary human macrophages were infected with wild type and D116A integrase 
mutant HIV viruses or lentiviral vectors and total genomic DNA was isolated at 
various times post infection. A diagram depicting how the D116A mutant 
lentiviral vector was produced by alteration of the packaging plasmid R8.91 
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Figure 23. Production of integration-defective lentiviral vector stocks. T h e D 1 1 6 A 
mutation w a s introduced into the pol reading frame of the lentiviral vector packaging 
plasmid pCMV-R8.2 (kind gift of D. Trono) to make pCMV-R8.2-D116A. The lentiviral 
expression plasmid pHR' was then altered by the insertion of an expression cassette 
encoding the gene for Secreted Alkaline Phosphatase (SEAP) (Clontech, Inc.) under the 
control of the elongation factor 1 alpha (EF-1) promoter to make pHR'EF-1-SEAP. 
SEAP-expressing non-integrating lentiviral vector stocks were produced by triple 
transfection of the pCMV-R8.2-D116A plasmid along with the pHR'EF-1-SEAP and a 
plasmid expressing the envelope protein from vestibular stomatitis virus (pMD.G). 
These non-integrating lentiviral vectors were then used to transduce primary human 
macrophages and SEAP production was measured at various time points post-
transduction. 
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As expected, the D116A integrase mutant virus produced more 2-LTR circle 
copies per cell compared to wild type HIV [Figure 24]. 2-LTR circle copy number 
per genomic equivalent peaked after 24 hours in D116A infected macrophages, 
while wild type circles peaked after 8 days. This difference in the rate of circle 
formation between wild type and integrase mutant viral infections may be due to 
the severity with which integration is disfavored with the D116A mutation, 
determined by Wiskerchen and Muesing to be by as much as five to ten 
thousand-fold [42]. There is no appreciable difference in the level of reverse 
transcription between the wild type and D116A viruses, evidenced by the parity 
of late RT products within infected macrophages. The decline of both late RT 
products and 2-LTR circle copies with time coincides with increased cell death in 
the macrophage cultures. 
Primary human macrophages were infected with wild-type as well as 
integration-defective (IN D116A) HIV-1 molecular clones, and total genomic 
DNA was isolated from these cells at various times post-infection. We were able 
to detect 2-LTR circles in macrophages from day 1 and up to 32 days post-
infection with the integration-defective HIV-1 viral species, but the circles were 
barely measurable in the wild type infected cells at the latest time point [Figure 
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Figure 24a. H I V 2-LTR circles are stable in primary human macrophages. Primary 
human macrophages were infected with wild-type R7/3-Yu2 (triangles) and integration-
defective D116AR7/3-Yu2 (circles) M-tropic HIV viruses (lOOng p24/106 cells). Total 
genomic and extrachromosomal D N A was isolated from infected macrophages at days 1, 
4, 8,16, and 32 post-infection. One hundred nanograms of D N A from each sample was 
analyzed for 2-LTR circle content via Real Time PCR. Peak copy numbers of 2-LTR 
circles were reached by Day 16 post-infection, with a 3 to 10-fold difference in 2-LTR 
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Figure 24b. p24 Gag expression in primary human macrophages following infection 
with wild type R7/3-Yu2 eGFP and D116A R7/3-Yu2 eGFP. Media samples were taken 
at the various time points (as above) and analyzed via ELISA assay for p24 Gag 
expression. The D116A mutant did not produce detectable levels of HIV gag, suggesting 
that LTR circles alone are incapable of sustaining a viral infection. 
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2-LTR circles decreased from peak levels (at day 16), which appears to correlate 
with the gradual disappearance of cells due to cell death. While we consistently 
observe a 10-fold elevation in 2-LTR circle copy number upon infection with the 
D116A mutant virus, we were unable to detect viral p24 Gag expression from 
macrophage cultures infected with the D116A integrase mutant virus [Figure 
24b]. Thus, our data indicate that 2-LTR circles are stable for at least one month 
in macrophages following infection with integration-defective HIV and they 
appear to persist throughout the life of the cell. In similar experiments, primary 
monocyte-derived immature dendritic cells were prepared as previously 
described [190] and infected with wild type or D116A mutant HTV on day 6 of 
the cultures. Infected cells were washed and total genomic DNA was isolated at 
two time points at day 2 and 14 post-infection. Quantification of 2-LTR circles 
present in the total genomic DNA samples from day 2 and Day 14 shows that the 
circles persist in immature dendritic cells through Day 14 post-infection. The 
D116A mutation produced a similar increase in circle copy numbers compared to 
wild type controls as was seen in macrophage infections using these same 
viruses. 
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II. 2-LTR circles express low levels of enhanced green fluorescent protein (eGFP) in 
macrophages 
Low levels of viral gene expression were evident from unmodified 2-LTR 
circles. Consistent with previous results, we were unable to detect viral p24 Gag 
expression from macrophage cultures infected with the D116A mutant version of 
R7/3, an HXB-2-derived proviral subclone of HIV-1 [191]. Similarly, 
macrophages infected with an integration defective macrophage-tropic R7/3 
variant, R7/3-Yu2-eGFP, which expresses the enhanced green fluorescent protein 
gene from the ne/position, displayed markedly decreased levels of eGFP 
compared to wild type controls [Figure 25]. The reasons for this lack of robust 
gene expression from unintegrated viral DNA templates is unclear, and may be 
caused by a variety of factors, including the supercoiled nature of the 
circularized DNA, the proximity of circles to transcriptional machinery in the 
nucleus, as well as the relative effectiveness of the viral 5' LTR promoter when 
the HIV genome is in circular form. Indeed, the presence of two LTRs side by 
side in the circularized viral DNA may cause promoter occlusion as an overload 
of transcription factors and other molecules that bind to the sequences in the 
LTRs could prevent the proper initiation of RNA polymerase II-mediated 
elongation. 
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III. Integration-defective VSV-G-pseudotyped lentiviral vectors express measurable levels 
of secreted alkaline phosphatase (SEAP) in macrophages 
In order to determine whether we could overcome possible negative 
effects on the 5'LTR promoter in 2-LTR circles and thus increase the level of gene 
expression from them, we constructed a series of lentiviral vectors that contained 
an internal promoter, EF-la (elongation factor la), positioned downstream of the 
LTR in the circularized viral DNA. The vectors were made integration defective 
by way of a triple mutation of the catalytic residues (DDE motif, D64A, D116A, 
E152A) [42] in the active site of the lentiviral integrase and addition of these 
vector stocks to primary human macrophages resulted in non-productive, single-
cycle infection with a characteristic increase of stable, unintegrated covalently 
closed circular viral DNA. We inserted the gene for Secreted Alkaline 
Phosphatase (SEAP) downstream of the EF-la promoter in order to serve as a 
reporter for circle-driven gene expression. Following infection with EF-la-SEAP 
2-LTR circle vectors, cells were washed thoroughly to remove non attached 
virions from their surface, fresh media was added, and the cells were maintained 
in culture for an additional seven days. 
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Figure 25. HIV 2-LTR circles express low levels of enhanced green fluorescent protein 
(eGFP) in macrophages. Macrophages at day 21 following infection with either M-tropic 
wild type R7/3-Yu2-eGFP (panel A), D116A -Yu2-eGFP integrase mutant HIV viruses 
(panel B), or mock infected (panel C) are shown at 40X magnification. The D116A IN 
mutant displayed low levels of eGFP expression when compared to wild type controls, 
suggesting that 2-LTR circles are capable of limited gene expression in primary APC. 
The data shown is representative of three independent experiments. 
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Analysis of infected cell supernatants using an ELISA based assay to 
detect SEAP, revealed that the insertion of a promoter (EF-la) internal to the 5' 
LTR resulted LTR circle gene expression levels that were 25% of a wild type, 
integration-competent vector with the analogous promoter/reporter combination 
[Figure 26]. SEAP gene expression from the 2-LTR circle vectors peaked at 4 
days, and did not decrease appreciably throughout the duration of the culture (8 
days). The presence of 2-LTR circles and SEAP had no apparent deleterious 
effects on cell viability in the infected cultures as determined by trypan blue 
exclusion. This data suggests that, with the proper promoters, 2-LTR circle gene 
expression can be moderately enhanced, and such modified lentiviral vectors 
may represent a novel platform for gene therapy in non-dividing cells like 
macrophages and imDC. 
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Figure 26. Integration-defective VSV-g-pseudotyped lentiviral vectors express 
measurable levels of secreted alkaline phosphatase (SEAP) in macrophages. 
Lentiviral vectors were engineered to be integration-defective by the introduction 
of an active site mutation (D116A) to the integrase portion of the pol reading 
frame in the packaging plasmid. The vectors were designed to express S E A P 
under the control of the elongation factor la promoter (EF-1), pseudotyped with 
the vesticular stomatitis virus envelope glycoprotein (VSV-g), and were then 
used to transduce primary h u m a n macrophages at an M O I of 10. After a 12 hour 
incubation with vector, cells were washed and fresh media w a s replaced in each 
well. Media w a s then collected at 4 days post transduction and analysed for 
S E A P expression by a chemiluminescent detection assay. Media from the 
washed cells as well as uninfected cells are included as controls. The data s h o w n 
is representative of two separate experiments. 
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Chapter 5. Summary and Conclusions 
I. Lv-1 species-specific lentivirus restriction occurs at an early stage of the HIV life cycle 
during reverse transcription 
Host cell factors that restrict murine retroviral infections have long been 
known [154]. However, the existence of cellular factors that restrict lentiviral 
infections in primates has only recently established. The data presented in 
Chapter 2 of this thesis and in published form [149] represents the first definitive 
example of a host cell activity that restricts the tropism of both HIV and SIV in 
monkey and human cells. Analysis of viral DNA intermediates following 
infection of both permissive and non-permissive primate cells revealed a striking 
replication defect for incoming virions at the step of early reverse transcription, 
which carried through to subsequent steps of late reverse transcription, and 
presumably affects nuclear import of restricted viral cores [Figure 11]. This host 
cell factor was originally called Lvl (lentivirus susceptibility factor 1), but 
subsequent studies have identified Lvl as the cellular molecule TRIM5-CX [165, 
166]. Indeed, figure 2 of the report by Stremlau and colleagues describing the 
identification of TRIM5-CX alpha as the lentivirus susceptibility factor shows a 
defect in early reverse transcription for incoming HIV virions in rhesus macaque 
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cells containing high levels of rhesus TR1M5-CX that is analogous to the defect w e 
observed in our initial experiments with Rh.F cells (also derived from macaque 
monkeys). Thus, the results of our initial studies, in conjunction with supporting 
reports from others, has now firmly established that the Lvl/TRIM5-cx host cell 
restriction factor exerts its effects at the early stages of viral life cycle, at a step 
following entry and prior to reverse transcription. 
As mutations in the CA proteins of the incoming virions, as well as the 
addition of saturating amounts of lentiviral particles can overcome the Lvl/ 
TRIM5-CX restriction [149,192], the most likely mechanism of action for this factor 
is to bind to incoming virions in a manner that prevents CA disruption and 
subsequent uncoating or the downstream formation of reverse transcription 
complexes and functional PICs. While this proposed mechanism of action for 
Lvl/TRIM5-(X has not yet been proven, several recent observations support this 
assertion. First, the binding of the cellular protein Cycolphilin A (CypA) to HIV 
capsids has been shown to protect incoming virions from the effects of Lvl / 
TRIM5-CX in vitro [193]. Second, the CypA binding site in the CA protein 
overlaps an important determinant of Lvl/TRIM5-cx restriction-factor 
recognition in humans and nonhuman primates [193,194]. Notably, the 
CA-CypA interaction is required for restriction of HIV-1 by certain nonhuman 
primates, but in humans the CA-CypA interaction facilitates HIV-1 infection, 
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presumably because it at least partially inhibits restriction factor 
recognition[193]. Thus, the preponderance of evidence points to the lentiviral 
CA protein as the main target for host cell restriction factors like Lvl/TRIM5-a. 
An interesting recent observation of lentiviral restriction in New World 
monkeys, such as the owl monkey (aotus trivirgatus), demonstrates the lengths to 
which some host species go to generate host cell restriction factors to prevent 
lentivirus infection. Sayah and colleagues [195] followed up on a previously 
paradoxical observation that CypA-deficient HIV virions were able to overcome 
the block to HIV infection in owl monkey (OMK) cells. Normally, CypA 
incorporation into virions enhances their infectivity [reviewed in [164,196-200] 
(presumably by protecting them from the binding of restriction factors, as 
described above), so the result in OMK cells was surprising, and compounded by 
the fact that reintroduction of CypA into these cells following CypA-specific 
RNA knockdown by RNAi failed to restore the antiviral activity [195]. Instead it 
was discovered that a hybrid molecule of TRIM5-(X and Cyclophilin, termed 
TRIMCyp, had arisen in owl monkeys via retrotransposon-mediated insertion of 
a cDNA containing CypA into the TRIM5-(X locus in the owl monkey genome as 
they diverged from old world primates [195]. This molecule, and not the 
traditional TRIM5-(X found in macaques (no TRIM5-isoform has yet been 
identified in owl mokeys), is believed to be responsible for the species specific 
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restriction of lentiviruses in these monkeys. Whether the exon shuffling that 
produced TRIMCyp was purely serendipitous, or the result of evolutionary 
pressure exerted by the hyper-infection of ancestral owl monkey populations 
with pathogenic lentiviruses to which they were previously susceptible remains 
unclear. Undoubtedly, future studies in this area will uncover some of the 
molecular intricacies that vertebrates use to outmaneuver the pathogens that 
infect them. 
II. 2-LTR circles are stable in primary human macrophages and may be a platform for 
gene therapy based vaccines 
During Human Immunodeficiency Virus-type 1 (HIV-1) infection, the viral 
integrase catalyzes a 3' OH processing reaction that serves to activate the linear 
viral DNA termini for a subsequent strand-transfer reaction in which viral DNA 
is covalently joined to the host chromosome. Sustained viral replication 
absolutely requires the integration of the viral DNA since full transcription 
competency is achieved only after the creation of the proviral state. However, 
when the catalytic activity of integrase is compromised by small molecule 
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inhibition or via specific point mutations in the catalytic core domain of the 
enzyme, unintegrated viral DNAs accumulate in the nucleus in the form of 1-
LTR and 2-LTR covalently closed circles [42, 175]. These viral LTR circles were 
believed previously to be labile byproducts of HIV infection[186], but our work 
as well as other recent studies [41, 201] has shown that they are inherently 
capable of limited expression of certain viral genes, namely tat and nef (as 
evidenced by the expression of our in-frame nef-eGFP fusions shown in Figure 
25). However, for reasons unknown, we were unable to demonstrate robust viral 
gene expression from unintegrated circular viral DNA, and integration defective 
viruses never produce detectable levels p24 gag expression within infected 
macrophages. The inability of 2-LTR circles to produce enough viral protein to 
sustain a persistent infection may be due to the inability of the major viral 
promoter, the 5'LTR, to function outside of the context of an integrated provirus. 
While other possible reasons for the reduction in gene expression from these 
circles, such as the level of DNA supercoiling and the proximity to transcriptional 
machinery, cannot be ruled out entirely, the results of our experiments with the 
EF-la-SEAP lentiviral vector system [Figure 26] suggest that the identity and/or 
conformation of promoter used to drive gene expression from 2-LTR circles is an 
important determinant of the amount of transcription they can support. 
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As the 2-LTR circles can easily be detected and quantified by real time 
PCR in cultures of macrophages and T cells, numerous groups have sought to 
use them as an indicator of recent HIV infection in order to glimpse the early 
moments of the establishment of viral latency in these cells [202]. A recent report 
by Sharkey et al. describing the persistence of episomal HIV intermediates in the 
PBMCs of patients on highly active anti-retroviral therapy proposed that 2-LTR 
circles can serve as a reliable marker of recently infected cells [203] . However, 
our data showing long-term survival of 2-LTR circles in macrophage cultures, as 
well as recent experiments from other groups showing the same in T cell lines, 
refute this assertion [204]. Similarly, in SupTl and MT-4 T cell lines the slope of 
the rate of decay of 2-LTR circles is very similar to the slope of the rate of cell 
division, suggesting that the decline of 2-LTR circles is primarily due to dilution 
during cell growth instead of rapid decay upon recent infection [204]. In 
addition, a recent study by Butler et al. showed that 2-LTR circles peaked in 
abundance at 24 hours and persisted indefinitely in aphidicolin growth-arrested 
SupTl cells, noting that declines in 2-LTR copy numbers in these cultures was 
due to the death of infected cells [174, 205]. This result is similar to what we 
observe in thirty-day macrophage cultures wherein 2-LTR circle copy numbers 
decrease over time, apparently due to cell death. As these episomal viral 
byproducts display a propensity to persist indefinitely inside of infected cells, 
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and it would be difficult to separate cells that had been recently infected with 
HIV from those that continuously harbored virus, we believe that measurment of 
2-LTR circles would not be a reliable marker of recent HIV infection in vivo. 
The data presented in this thesis indicates that 2-LTR circles persist until the 
point of cell death in macrophages, following infection with wild type or 
integration defective HIV. Using sensitive molecular beacon-based real time PCR 
assays, we have tracked the appearance of viral DNA intermediates, including 
early and late reverse transcription products, as well as 2-LTR circles at various 
times post-infection. In addition, we monitored the capacity of integration-
defective HIV viruses to express the viral p24 Gag protein in antigen presenting 
cells. We were able to enhance the level of gene expression to one-fourth that of 
wild type by placing a defined promoter-driven transcriptional unit (EF-la-SEAP 
cassette) in a location that would be internal with respect to the 5'LTR once the 2-
LTR circles form in the nucleus. As these experiments were performed in a non-
dividing antigen presenting cell (macrophages), these results suggest that 
lentiviral vectors modified to form 2-LTR circles may be worth exploring in gene 
therapy settings. The non-toxic nature and persistence of such gene expression 
episomes would avoid some of the pitfalls that have been seen with other 
retrovirus-based gene therapy vectors, such as the insertional mutagenesis which 
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lead to lymphoma in patients treated with M L V vectors used in human clinical 
trials for severe combined immunodeficiency syndrome [206-210]. Indeed, if a 
sufficient level of continuous HIV gene expression from stable 2-LTR circle 
templates is capable of priming anti-viral immune responses, then HIV integrase 
inhibitors might have expanded immunological benefits in addition to their 
ability to lower viral load. In addition, if additional alterations to 2-LTR circle 
architecture (such as the inclusion of elements, like scaffold attachment regions, 
that link them to areas of active gene transcription in the nucleus), can further 
increase in their capacity to express genes, then non-integrating lentiviral vector 
systems may become the platform of choice for gene therapy applications in the 
future. 
III. The carboxyl terminus of HIV-1 integrase specifies a transferable nuclear localization 
signal (IN NLS) that functions in primary cells 
In previous studies, systematic mutagenic analysis was employed to 
identify a potent nuclear localization signal (NLS) within the carboxyl-terminal 
domain of HIV-1 integrase [167]. A region was identified spanning the charged-
clusters of basic amino acids at residues 236/240 and 262/263/266 and 
overlapping with a previously defined SH3 structural motif [168, 211, 212] that 
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had profound effects on HIV IN import in the context of IN-eGFP fusion 
proteins. In contrast to several earlier studies by others, we employed a novel, 
codon-optimized version of HIV-1 integrase that enabled us to observe the effects 
of NLS mutations on the nuclear accumulation of the native integrase protein. We 
further demonstrated that the carboxyl-terminal NLS is transferable—when 
fused in a variety of configurations to proteins that are otherwise cytoplasmic it 
confers nuclear localization to the chimeric molecules. Importantly, this 
transferable NLS was functional in non-dividing cells that support HIV infection 
in vivo, such as immature dendritic cells and CD8-depleted (CD4+) peripheral 
blood lymphocytes. That the IN NLS mutations prevented nuclear import of 
large cargo proteins in non-dividing cells minimizes the possibility that they 
simply coordinate integrase binding to chromosomal DNA. 
Virions incorporating NLS mutations are intact with respect to integrase 
catalytic function as well as to other biochemical parameters. However and more 
importantly, a quantitative analysis of viral DNA intermediates formed during 
infection of primary lymphocytes and macrophages (cell-types critical for the 
propagation of HIV-1 in vivo) revealed a profound two- to three- log defect 
specific to the nuclear import of mutant viral DNA. In addition, when these IN 
NLS mutants were used to make fluorescently tagged Vpr-GFP virions, live cell 
imaging of macrophage infections with these viruses reinforced the results 
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obtained in the real time PCR and eGFP-MBP nucleofection experiments, as a 
nuclear excluded phenotype was observed in cells infected with the IN NLS 
mutant virus compared to the wild type IN NLS virus. 
Interestingly, unlike canonical nuclear localization signals, the IN NLS 
activity cannot be transferred as a small peptide unit but instead requires the 
region of the protein spanning residues 220-270 [167]. When this region of HIV 
integrase is dimerized in solution, each monomer adopts an SH3-like fold [211, 
213]. In this configuration, a highly charged surface is created at the solvent 
interface by the contribution of the basic residues at positions 236/240 and 262/ 
263/266, each cluster contributed by a separate monomeric unit. Thus, 
orientation of the constituent residues of the IN NLS within the context of a 
larger three-dimensional space may be critical to its function as a facilitator of 
viral nuclear import. Although SH3 domains are not generally thought to interact 
with the nuclear transport machinery, at least one example of this type of 
interaction has been described. The SH3 domain of the human T-cell tyrosine 
kinase, Itk, has been reported to interact directly with a karyopherin-a (Rchla) in 
vivo and this interaction is necessary and sufficient for T-cell receptor signal-
regulated nuclear transport of the Itk protein [214, 215]. The fact that our mutants 
are defective in dividing as well as non-diving cells is concordant with recent 
data indicating that nuclear translocation of the HIV-1 genome is independent of 
109 
mitotic nuclear disassembly [216]. In fact, these studies reveal that the nuclear 
transport of viral DNA is actually delayed during as the cell undergoes mitosis 
[216], a result previously unanticipated and widely thought to be 
counterintuitive, as the nuclear membrane would be broken down during 
mitosis and the virus should have free access to the nucleus under these 
circumstances. 
Similar to many previously identified N L S sequences, the residues which 
contribute to the integrase NLS are contiguous with, but distinct from, specific 
residues important for DNA binding. Although basic residues are critical for NLS 
activity, there is little homology to classic, bipartite, or basic NLSs such as that of 
nucleoplasmin (NP) and a karyophilic binding partner for integrase has not yet 
been identified. In previous reports, Gallay and colleagues stated that HIV-1 IN is 
brought to the nuclear pore through the interactions of karyopherin-alpha with 
karyopherin-beta [217, 218]. However observations reported by Depienne et al. 
[219] suggest that IN can dock at the nuclear pore and enter the nucleus in their 
absence of these nuclear transport receptors. The basis for this discrepancy 
remains to be determined, but is likely attributed to the difference in reagents 
(specifically the type recombinant integrase proteins) used in the various studies, 
or the isotype of the karyopherins and other reagents used in the nuclear import 
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assays. For example, the report by Depienne et al. relied upon a purified 
integrase protein conjugated to a fluorescent molecule (Cy3). Their observation 
that this fluorescently conjugated IN molecule can localize to the nucleus in the 
absence of cytosolic factors (including the karyopherins) does not necessarily 
prove their conclusion that IN mediated nuclear import is karyopherin-
independent because the addition of the Cy3 moiety could affect IN 
oligomerization, allowing it to passively diffuse through the NPC as a single 
molecule (32kD, below the NPC exclusion limit) where it binds to DNA and 
appears nuclear, or otherwise influence the trafficking of the native IN molecule. 
In contrast to the Depienne et al. report, our results with the eGFP-MBP fusion 
proteins suggest that the C-terminus of integrase must interact in some manner 
with the host nuclear import machinery in order to carry this large protein cargo 
through the NPC. 
Additional support for the notion that integrase mediated nuclear import 
involves host cells factors is found in three recent publications describing host 
proteins that interact with HIV-1 integrase. These molecules include LEDGF 
[220], importin7 [221] and EED [222] all of which have biochemical and 
cytological characteristics that certainly warrant further investigation. LEDGF 
and Importin7, have been shown to interact with HIV-1 integrase in a manner 
that is consistent with either a role in the chromosomal targeting of the integrase 
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protein [220], or a function in the nuclear import of the viral RT complex itself 
[221]. In the case of LEDGF, this interaction is dependent upon the amino-
terminal and core domains of integrase, as the carboxyl-terminal domain is 
reportedly dispensable for this interaction in vivo [220, 223]. However, our data 
indicates that the IN C-terminal domain alone is both necessary and sufficient for 
localization to the nucleus. A plausible explanation to reconcile these apparently 
disparate results is that LEDGF simply anchors HIV-1 integrase to host 
chromosomes after nuclear import has occurred, as the size of the HIV IN amino-
terminalcore domain segment used in their experiments is roughly 23 kD, well 
below the 60 kD exclusion limit of the nuclear pore. 
Importin7 (an isoform of karyopherin oc) acts as a heterodimer with 
importm-p* (karyopherin 3) to facilitate the nuclear import of histone HI [224], 
certain ribosomal proteins [225, 226], as well as the RT complexes associated with 
genomic HIV-1 import in permeabilized cells [221]. Although importin7 has been 
reported to interact with the HIV-1 integrase protein in vitro, the experiments 
performed to demonstrate this interaction required the addition of HeLa cell 
cytoplasmic extract to the system in order to be detected [221]. Therefore, it is 
possible that the contribution made by importin7 to nuclear import of RT 
complexes may not result from its direct interaction with integrase per se, but is 
instead coordinated through a complex of importin7/karyopherin (3, integrase, 
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and some other as-yet-unidentified "bridging" molecule(s) in the cytosolic 
extract. A good candidate for such a potential bridging molecule the is human 
embryonic ectoderm development (EED) protein, which has been shown to bind 
integrase in vitro [222]. Interestingly, EED also binds other HIV proteins, namely 
Matrix and Nef [227, 228], suggesting that association with this cellular protein 
may provide the virus with a replicative advantage. 
EED belongs to the polycomb group of proteins (PcG) [229] that were 
originally identified in Drosophila melanogaster as nuclear proteins containing 
multiple copies of the WD-40 repeat [230] that act to remodel chromatin by 
altering the accessibility of DNA to factors required for gene transcription [231]. 
Homologues of these proteins are highly conserved in mammals [232]. 
Significantly and quite unexpectedly (as integrase's toxicity to yeast cells has 
confounded earlier attempts to define its binding partners) the EED protein has 
been shown to interact strongly with the HIV-1 integrase protein in the context of 
a yeast two-hybrid system [222]. This interaction appears specific for the 
carboxyl-terminal domain of integrase. Perhaps most interestingly, the specific 
binding between integrase and EED can be competed against in vitro with 
recombinant bacteriophage that display peptide segments that map to the 
identical set of charged-cluster amino acid residues that we have identified as 
critical to integrase NLS function in vivo. 
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In humans, a molecule that is homologous to drosophila E E D in both 
DNA and amino acid sequence, has been described independently as a protein 
that binds to the cytoplasmic domain of the integrin beta-7 subunit, alpha-4, beta 
-7 [233]. This protein, designated WAIT-1 (WD-40 repeat protein Activated In T-
Cells) was initially characterized in circulating lymphocytes where it appears to 
be involved in the transduction of signals arising from the integrin beta-7 
receptor [233]. In lymphocytes, signals arising from the integrin receptor are 
thought to be transmitted via EED/WAIT-1 from the inner plasma membrane 
into the nuclear compartment to affect regulation of inducible gene activity [233]. 
As would be expected for a protein involved in control of transcription, EED/ 
WAIT-1 is localized predominately to the nucleus in cycling cells as determined 
by its fusion to a fluorescent indicator protein [234]. Thus, EED/WAIT-1 would 
provide all of the essential features that incoming PIC, and the integrase C-
terminal NLS contained within it, might desire in potential a binding partner, 
including a propensity to rapidly localize to the nucleus in activated T cells, the 
natural target cells for HIV infection in vivo. 
Structurally, EED/WAIT-1 displays some features that would support its 
potential role as a binding partner for our IN NLS during viral nuclear 
translocation. Of particular interest is the proline-rich N-terminal region of the 
proteins which harbors two closely spaced PXXP motifs—a motif commonly 
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found in inter- or intra-molecular interactions with SH3 domains [235]. 
Interestingly, prolines at P60XXP63 in EED/WAIT-1 exist in the context of a 
sequence known for other proteins to be utilized to coordinate SH3 domain 
binding [236]. Finally, EED /WAIT-1 has been demonstrated to associate rapidly 
with regions of the nuclear membrane near the nuclear pore complex following 
infection with HIV-1 [222]. Importantly, integrase co-localizes with EED/WAIT-1 
at the pore peaking at 6 hours post-infection, consistent with our results showing 
that this same time frame is sufficient for nuclear localization of our Vpr-GFP 
tagged viruses [see Figure 22] [222]. Future studies of HIV nuclear import 
should seek to clarify the interactions between sequence motifs such as the C-
terminal NLS in HIV IN described in this work, and soluble cellular factors such 
as EED/WAIT-1 and karyophilic molecules like importin7. Generating a detailed 
understanding of the molecular events and sequence motifs that support HIV's 
specific nuclear import pathway will be vital to our ability to discover novel 
antiviral compounds that block this critical step of the early viral life cycle. 
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Future Studies: 
I. Ligand blot methodology may reveal interactions between HIV integrase and host 
factor(s) that facilitate viral nuclear import 
Nuclear pore complexes can be isolated by biochemical means and 
subjected to two-dimensional gel electrophoresis under denaturing conditions. 
This results in a characteristic banding pattern of nuclear pore proteins that can 
be transferred to nitrocellulose and probed by standard Western blotting 
techniques. In order to discern whether a given recombinant protein or 
multiprotein complex (i.e. an HIV PIC) is capable of binding to nuclear pore 
proteins, one can use a solution of that protein in place of the primary antibody 
to probe nuclear pore blots in a technique called ligand blotting [237, 238]. The 
recombinant protein or complex could be used in isolation or in the presence of 
specific cytosolic extracts containing requisite accessory factors (such as 
karyopherins or other adaptor molecules) that facilitate nuclear pore protein 
binding. This is followed by detection of the protein in question, in this case HIV 
integrase, with specific monoclonal antibodies, such as the mouse monoclonal 
antibody 6G5, that is specific for the N-terminus of the enzyme. By using 
recombinant HIV-1 integrase and PICs (both wild type and NLS mutant) on such 
nuclear pore ligand blots in the presence of cytosolic extracts from various 
primary cell types that naturally support HIV infection including activated CD4+ 
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T lymphocytes macrophages w e plan assess which nuclear pore components 
bind HIV integrase in vitro. An example of a preliminary experiment using ligand 
blot methodology with wild type and NLS mutant HIV PICs is shown in Figure 
27. It appears that HIV integrase binds to numerous constituent proteins in the 
rat liver nuclear pore complex including the lamins, histones, and possibly some 
of the smaller nuceloporins. Future experiments are envisioned in which varying 
concentrations of suspected integrase-binding adaptor molecules, such as EED 
and LEDGF, as well as other viral proteins thought to be involved in nuclear 
import (i.e. MA, Vpr), are titrated onto ligand blots to determine the extent of 
their contribution to nuclear pore binding. 
II. PIC immunoprecipitation may reveal differences in wild type and NLS mutant virus 
interactions with FG nucleoporins in the NPC 
Extraction of rat liver nuclei with the zwitterionic detergent, empigen, results in 
an enrichment of some of the higher molecular weight constituents of the nuclear 
pore complex. Large FG nucleoproins like Nup358, Nup214, and Nupl53 are 
present in these empigen extracts, along with Nup62 and other FG nups [83]. 
When purified cytosolic extracts from HIV infected macrophages are added to 
empigen extracted rat liver nuclei, it may be possible to discern differences 
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between wild type and N L S mutant virions with respect to their ability to bind to 
FG nups by attempting to immunoprecipitate bound FG nups with antibodies 
specific for viral proteins, such as the anti-IN N-terminus monoclonal antibody 
6G5. A diagram decribing the reparation of HIV pre-integration complexes 
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Figure 27. Ligand blotting of rat liver Nuclear Pore Complexes with W T and NLS 
mutant PICs. Rat liver nuclei were isolated, detergent solubilized, and run on a 4-20% 
Tris-Glycine gel (2 units per well). Nuclear proteins including lamins, histones, and 
nucleoporins were transferred to a nitrocellulose membrane by Western blotting and the 
blot was cut into strips well by well. Each strip was placed in a well of an 8-well tray, 
blocked with 3% non-fat dry milk, and incubated for 2 hrs at room temp with purified 
PICs from wild type and NLS mutant infected macrophages. A monoclonal antibody to 
the N-terminus of IN was then added (mAb6G5) and detected with an anti-mouse HRP-
conjugated secondary antibody. Cytosolic extract from uninfected macrophages was 
included as a control under the same staining conditions (lane 7). A) Ligand blot of rat 
liver N P C with HIV PICs reveals numerous nuclear proteins that are reactive with HIV 
integrase. B) A stained blot of rat liver N P C with bands that have been identified by 
mass spectometry [ref 119]. Comparison with the ligand blot suggests that HIV IN in the 
context of PICs binds to histones (H2b, H2a, HI, and H4), lamins (lamin C), and perhaps 
some smaller nucleoporins (Nup54, Nup45, and p42). Data are representative of two 
independent experiments. 
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Figure 28. Preparation of pre-integration complexes (PICs) from HIV-infected 
macrophages. Primary human macrophages were infected with high amounts of HIV 
(MOI of 10,000), and infection was allowed to proceed for 6 hours at 37°C, to allow 
reverse transcription and subsequent PIC complex formation. After 6 hours, infected 
cells were washed twice with hypotonic lysis buffer, then incubated in ice-cold 
hypotonic lysis buffer with 50^g/mL digitonin detergent. Lysed cells were physically 
disrupted by passaging through a 25-gauge blunt needle and syringe, then cytosolic and 
nuclear extracts were made according to the protocol found in the Materials & Methods 
section. Cytosolic extracts were then snap frozen in liquid nitrogen then stored at -80°C 
until use in digitonin-permeabilized cell assays. 
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Figure 29 shows an example of an experiment in which PICs from cells 
infected with wild type and NLS mutant viruses were incubated with empigen-
extracted rat liver FG nuceloporins and immunoprecipitated with an anti-
integrase monoclonal antibody. Immunoprecipitated samples were separated on 
a SDS-PAGE gel by electophoresis, transferred to nitrocellulose membrane, and 
probed with an antibody specific for FG nucleoporins (mAb-414, courtesy of Dr. 
Elias Coutavas, Blobel lab, Rockefeller U.) Small, FG nup antibody reactive 
proteins are noticeable in the lanes containing wild type, D116A, and K236/240A 
PICs that appear absent in the other NLS mutant PIC lanes (R262/3/6A and 
260stop). These bands may be the result of a proteolytic activity that is 
specifically active during wild type or K236/240A mutant infections that is 
absent or inhibited in R262/3/6A and 260 stop infections. Or, they may represent 
small FG nups that wild type virions (and K236/240 virions to a lesser extent) 
bind to during viral nuclear import. Future studies are envisioned using this 
PIC-empigen-extracted NPC immunoprecipitation assay in the presence of 
different molecules, such as recombinant EED (or PXXP mutants of EED, 
incapable of binding to HIV IN), as well as recombinant importin7 to reveal the 
complexes interactions that likely occur between HIV PICs and the FG 
nucleoporins during viral nuclear import. 
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Figure 29. Immunoprecipitations with empigen-purified N P C and H I V PICs. Rat 
liver nuclei were extracted with the zwitterionic detergent empigen to create an 
enriched source of the higher molecular weight nucleoporins. Empigen purified 
N P C were mixed with PICs from macrophages infected with wild type or N L S 
mutant viruses, incubated for 2 hours at 4 degrees in the presence of protease 
inhibitors and mild RIPA buffer, then immunoprecipitated with anti-integrase N-
terminus antibody m A b 6 G 5 and protein A sepharose. Immunoprecipitated 
complexes were washed with buffer, heat denatured, run on 4-20% Tris-Glycine gel, 
then blotted onto nitrocellulose. The blot was then probed with mAb414, a 
monoclonal antibody that is specific for FG-containing nucleoporins. A) Western 
blot of immunoprecipitated PICs /nucleoporins. Several diffuse smaller bands of 
unknown identity are visible in the W T , D116A, and K236/240A wells. B) Western 
blot of empigen extracted rat liver N P C probed with mAb414 [ref 83]. C) Schematic 
diagram of the nucleoporins as they appear in the N P C [ref 122]. Data shown are 
representative of three independent experiments. 
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chapter 6. Materials and Methods 
Construction of Plasmids 
EGFP-IN expression vectors contained the coding sequence for enhanced green 
fluorescent protein (Clontech), upstream of an HIV-1 IN open reading frame 
derived from the CXCR4-tropic, HXB-2 subclone, R73. This gene fusion was 
cloned into pcDNA3.1 (+)-CTE, a derivative of pcDNA3.1 (+) (Invitrogen), that 
includes the constitutive transport element (CTE) from Mason-Pfizer monkey 
virus. A synthetic, codon-modified IN gene, IN-MOD (GenBank Accession 
#AF422697), was constructed by primer extension of overlapping 100 base-pair 
oligo-nucleotide segments and cloned into pcDNA3.1 (+)-CTE to create the 
modified integrase expression plasmid, pcDNA3.1 (+) IN-MOD-CTE. The natural 
version of the viral integrase gene from R73, IN-VIR, was cloned into pcDNA3.1 
(+)-CTE to create the cognate, viral integrase expression vector, pcDNA3.1 (+) 
IN-VIR-CTE. These plasmids are identical except for the segment encoding the 
wild-type integrase amino acid sequence. For the plasmids used in the eGFP-
MBP-IN NLS transfection and nucleofection studies, the C-terminal portion of 
the IN MOD gene was amplified by PCR and inserted at the C-terminal end of a 
gene encoding an enhanced green fluorescent protein (eGFP)-maltose binding 
protein (MBP) fusion protein in the context of a CMV expression vector plasmid. 
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For viral studies, the relevant mutations were subcloned into derivatives of R73. 
In some cases, the envelope gene of R73 was replaced with that of the 
macrophage-tropic primary isolate, R73(YU-2). 
Preparation of Primary Immune cell populations 
Immature Dendritic Cells 
Primary human immature dendritic cells were prepared by CD14+ magnetic 
bead separation of CD 14+ monocytes from peripheral blood mononuclear cells 
(PBMCs) obtained from blood donors. In general, 50ml of a human leukocyte 
concentrate (from 500ml of whole blood, LEUKOPAK (from the New York Blood 
Center) is mixed 1:1 with IX phosphate buffered saline (PBS) in a T75 culture 
flask. Approximately 33ml of this 1:1 PBS:Blood mixture is layered onto 10ml of 
Ficoll paque (Pharmacia) into each of three 50ml Falcon polypropylene tubes, 
then tubes are centrifuged at 2000 rpm for 20 minutes at room temperature with 
the brake off. Following this centrifugation step, a layer of PBMCs is visable in 
each tube between the plasma (top) and red blood cells (bottom). This layer of 
PBMCs is collected from each tube and placed in a fresh 50ml Falcon tube then 
the volume is adjusted to 50ml with PBS. Cells are then centrifuged at 1200 rpm 
for 10 minutes at 4°C to pellet the PBMCs. The PBMC pellet is then resuspended 
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in 3ml of A C K red blood cell lysis buffer (Bio-Whittaker) and incubated at room 
temperature for 5 minutes. The volume is then adjusted to 50ml with cold PBS 
and the cells are centrifuged at 1200 rpm for 10 minutes at 4°C to pellet. Cells are 
then resuspended and washed with 50ml cold PBS two more times. A lO^il 
aliquot was taken before the final centrifugation, added to lOul of trypan blue 
solution (Cellgro) on a piece of parafilm, then added to a hemocytomer for cell 
counting while the tube of PBMCs is spinning. 
The PBMC pellet was then resuspended in MACS buffer (0.5% Bovine Serum 
Albumin/PBS) by adding 80^1 of MACS buffer per 1 x IO7 PBMCs. CD14+ 
magnetic beads (Miltenyi Biotech) were added at lOul per 1 x IO7 cells, mixed by 
pipetting and stored at 4°C for 20 minutes to allow for binding. Cells were then 
washed by adding 20-fold increase of volume of MACS buffer, then 
centrifugation at 1200 rpm. CD14+ labeled PBMCs were then resuspended in 
lml of cold MACS buffer, and added to a washed (with 5ml of cold MACS 
buffer) LS magnetic column mounted on a mini-MACS magnetic stand (Miltenyi 
Biotech). Cells were allowed to flow through by gravity then the column was 
washed twice with 5ml of MACS buffer. The CD14- fraction (flow through) was 
collected and saved for the preparation of CD4+ T cells (see below). The CD14+ 
monocytes were collected by removing the LS column from the magnet, adding 
5ml of MACS buffer, then pushing the cells through with a plunger into a 15ml 
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Falcon tube. Aliquots (lOul) were taken for counting, and cells were centrifuged 
at 1200 rpm for 10 minutes at 4°C. 
CD14+ monocytes were resuspended at a concentration of 1 x 106 cells/ml in cell 
culture medium, supplemented with cytokines. The cell culture medium used 
throughout was complete RPMI 1640 (Cellgro) supplemented with 2mM L-
glutamine (GIBCO-BRL Life Technologies), 50|JM 2-mercaptoethanol (Sigma), 
lOmM HEPES (GIBCO-BRL Life Technologies), penicillin (100 U/ml)-
streptomycin (100Mg/ml) (GIBCO-BRL Life Technologies), and 1% heparinized 
human plasma (Rl media). Recombinant human (rh) IL-4, was purchased from 
R&D Systems and used at a final concentration of 100 Units/ml, recombinant 
human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was 
bought from Immunex and used at a final concentration of lOOOU/ml. Every two 
days, 200|jl of fresh Rl media was added to each well supplemented with GM-
CSF (1000 U/ml) and IL-4 (100 U/ml). Immature dendritic cells were then 
harvested between days 6-8, and a small aliquot was removed for FACs analysis. 
CD4+ T cells 
Primary human CD4+ T cells were isolated by negative selection using the CD14-
PBL fractions from the immature DC preps described above. Briefly, a cocktail of 
antibody-conjugated magnetic beads (Miltenyi Biotech) was added to CD14-
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PBLs which include: anti-CD8 (removes CD8+ CTLs), anti-HLA-DR (removes 
residual APCs), anti-CDllb (removes monocytes and granulocytes), and anti-
CD19 (removes B cells). The magnetic beads were added at an equal fraction 
based on the parameters described above (lOpil of each type per IO7 CD14- cells). 
Cells were incubated with beads for 20 minutes at 4°C, then washed by adding 
20-fold increase of volume of MACS buffer, then centrifugation at 1200 rpm. 
CD4+ T cells were negatively selected by adding them to and collecting the flow 
through from a LS column attached to a miniMACS magnet as described above. 
CD4+ T cells were then pelleted by centrifugation at 1200rpm for 10 minutes. 
After centrifugation, cells were resuspended at high density (1 x IO7 cells/ml) in 
Rl media supplemented with 5ng/ml of recombinant human IL-2 (Boehringer 
Mannheim) and maintained in culture with fresh media added every 2 days until 
use. 
Macrophages 
Primary human macrophages were derived from the same CD14+ monocyte 
populations used to make immature DC above. Briefly, CD14+ monocytes were 
resuspended in Rl media and plated at 1 x IO5 cells per cm2 in 24-well tissue 
culture plates containing round 12 mm glass slides (Fisher Scientific) that had 
been treated beforehand with poly-L-lysine (Sigma), for 20 minutes at room 
temperature, then washed twice with PBS. Monocytes were incubated in a 37°C 
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incubator with 5 % CO2 for six to seven days, then the Rl media was removed 
and replaced with fresh Dulbecco's Modified Eagle Medium (DMEM, Cellgro), 
supplemented with 10% Fetal Bovine Serum (FBS, Cellgro). 
FACS analysis of Primary Immune cells 
Phenotyping of immature dendritic cells 
For FACs analysis of primary human immature dendritic cells, 2xl04 DCs per 
well of a 96-well V-bottomed plate (100u4 per well). Huorescently-labeled 
antibodies were added at the following concentrations per lOOul cells: IgGlPE(l: 
50), IgG2bPE (1:50), IgG2a-FITC(l:200) controls, IgGIPE (1:50), IgG2bPE (1:50), 
HLA-DR-FITC (1:200), CD25-PE(1:50)/HLA-DR-FITC(1:200), CD80-PE(1:50)/ 
HLA-DR-FITC, CD83-PE (1:50) (Immunotech) / HLA-DR-FITC, and CD86-PE (1: 
50)/HLA-DR-FITC. FITC and PE-conjugated antibodies were from BD 
Pharmingen unless otherwise noted. The V-bottomed plate was then covered 
with aluminum foil and incubated for 20 minutes (or overnight) at 4°C in the 
dark in a refrigerator. After incubating with antibodies, 100u4 of FACS wash 
(PBS/5% FCS/0.1% Azide) was added, and mixed by pipetting. Then the cells in 
each well were pelleted by centrifuging the plate for 2-3 minutes at ~2500rpm. 
Aspirated off approximately half of the volume, added 100|jl of FACS wash, 
centrifuge at the above time and speed and repeat twice more (4 spins in total 
After the 4th spin, aspirate of half of the volume and add 100|jl of FACS fix (10% 
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formalin in PBS). Store the fixed, stained cells in the fridge (covered in foil) until 
ready to analyze on FACs Calibur fluorescence-activated cell sorter (Becton 
Dickinson). The cells were acquired (5-10,000 events), gating on large DCs and 
the HLA-DR+ cells were assessed. Immature DCs are HLA-DR+ and express 
moderate CD86 and at best low levels of CD80, while CD25 and CD83 are 
typically not expressed on the immature DC surface (CD83 is expressed 
intracellularly). All of the DC used in the nucleofection and other experiments 
described in this thesis were of the immature phenotype. 
Phenotyping ofCD4+ T cells 
FACs analysis of CD4+ T cells was performed in the same manner as for the 
immature dendritic cells described above, with the exception that different 
antibodies were used for staining. Briefly, CD4+ T cells were stained with the 
same controls: IgGlPE(l:50), IgG2bPE (1:50), IgG2a-FITC(l:200), IgGIPE (1:50), 
IgG2bPE (1:50), and the following specific antibodies, along with a constant CD3-
FITC-labeled antibody: CD4-PE(1:50)/CD3-FITC(1:50), CD8-PE(1:50)/CD3-FITC, 
CDllb-PE(l:50)/CD3-FITC, CD14-PE(1:50)/CD3-FITC, CD25-PE(1:50)/CD3-FITC, 
CD38-APC(CalTag)(l:50)/CD3-FITC, and CD69-PE(1:20)/FITC. FACS analysis was 
performed as above on the FACs Calibur sorter gating on small CD3+ T cells (5-10,000 
events). The CD4+ cells used in the nucleofection experiments were CD4-high, CD8-
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negative, CD14-negative, CD25-low, CD38-low, and CD69-low, indicating a naive CD4+ 
T cell phenotype. 
Cell Culture, Transfections, Nucleofections, and Virus Production 
HEK293T and CEM-SS cells were maintained in the appropriate media (DMEM 
(Cellgro) supplemented with 10% Fetal Bovine Serum (Cellgro). Macrophages 
were prepared by monocyte isolation from the peripheral blood mononuclear 
cells (PBMC) of normal blood donors either by density gradient centrifugation on 
46% Percoll (Amersham Pharmacia Biotech), followed by plastic adherence for 1 
hour at 37°C and culture for 6 days in RPMI-1640 with 2% Human AB serum 
(Sigma) or by CD14-magnetic bead cell sorting (MACS procedure, Miltenyi 
Biotech, described above) before infection. For primary dendritic cells and CD4+ 
T cells, ficoll purified PBMCs were incubated with CD14-specific microbeads 
(Miltenyi Biotech) and CD14+ monocytes were isolated over LS columns 
according to the manufacturer's protocol. These CD14+ monocytes were 
cultured in GM-CSF (100 U/ml) and IL-4 (10 U/ml) for 6 days, with fresh 
cytokines and media added every two days until cells resembled immature 
dendritic cells on FACS analysis as described above. Activated CD8-depleted 
peripheral blood leukocytes (PBL) were generated from the same donor-matched 
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P B M C samples used to prepare the macrophages, by removing C D 8 positive cells 
from the CD14- fractions remaining after monocyte removal with anti-CD8 
magnetic beads according to the manufacturer's protocol (Dynal, Inc.). All viral 
stocks were prepared in transfected 293T cells filtered through 0.45 mm filters 
and treated with DNase I (Sigma) at 8 mg/ml for 30 minutes at 37°C. 
Nucleofection with AMAXA kit 
For nucleofection experiments, the remaining, CD14- cells were subjected to 
further purification using magnetic beads specific for HLA-DR, CDllb, CD19, 
and CD8 and a population of approximately 96% (by FACS) pure CD4+ T cells 
was isolated and cultured at high density (1 x IO7 per ml) in media supplemented 
with 5ng/ml recombinant human IL-2. At day six of each culture, cells were 
collected, pelleted by centrifugation, and resuspended to 2.5 x IO5 cells/ml in 
either T cell nucleofection solution (AMAXA Biotech) or dendritic cell 
nucleofection solution depending on the cell type. One hundred microliters of 
either cell suspension was mixed with 5|Jg of each eGFP-MBP-IN plasmid DNA 
in a microfuge tube, then transferred to a specialized electroporation cuvette and 
placed in the nucleofection device using program U-14 or U-02 according to the 
manufacturer's protocol (AMAXA Biotech). Nucleofected cells were 
immediately re-equilabrated in warm (37°C) media and incubated at 37°C with 
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5 % CO2 for 12 hours. After 12 hours, cell aliquots from each condition were 
taken and adhered (in serum free media, lOOpl cells/slide) to alcian blue/poly-L-
lysine (Sigma) coated 12 mm circular glass slides (Fisher Scientific), then fixed 
with 4% paraformaldehyde (Tusoumis), permeabilized with 0.1% Trition-XlOO / 
PBS (Sigma), washed 3 times with PBS, and mounted with DAPI containing 
mounting medium (Vectashield). In some experiments, nucleofected CD4+ T 
cells were sorted for GFP expression (Peter Lopez, AD ARC Mo-Flo facility) and a 
more concentrated population of nucleofected T cells were used to make slides 
for analysis on Delta Vision. This resulted in clearer microscope images, as much 
of the post-nucleofection dead cell debris was removed by the sorting. 
Generation of HIV Virus and Lentiviral Vector Stocks 
All virus and lentiviral vector stocks were generated by transient transfection for 
plasmid DNAs into HEK 293T cells. Briefly, 4 x IO6 cells were seeded into 75 cm2 
tissue culture flasks (Falcon BD). After 12-16 hours, a transfection mixture 
containing viral DNA (10|Jg of each HIV R73 plasmid DNA), the cationic lipid 
DMRIE-C (30ul) (Invitrogen), and Opti-MEM media (6ml) (Invitrogen) was 
added to the cells and allowed to incubate on cells for 16-24 hours. Transfection 
mixture was then removed and fresh DMEM-10% FBS media was added back to 
the transfected cells. Cell supernatants containing virions were harvested at 24 
-48 hours later, filtered through 0.45 urn syringe filter (Millipore), and stored 
132 
frozen in 1ml aliquots at -80°C until use. In the case of lentiviral vector stocks, 
10|Jg of an expression plasmid, 15[Jg of a packaging plasmid, and 5pig of a VSV-g 
envelope plasmid, and 50^1 DMRIE-C were co-transfected under the same 
conditions as above. For generating the Vpr-GFP HIV virus stocks, 10ng of a 
Vpr- HIV-R73-Yu2 molecular clone plasmid DNA was added with 5ug of a 
plasmid specifying a Vpr-GFP fusion protein (kind gift of Dr. Tom Hope, 
University of Chicago), along with 30 nl of DMRIE-C reagent in 6ml total volume 
of Opti-MEM, and transfection of 293T cells was performed as described above. 
For the still images shown in Figure 22, 500ng p24 was added to each well of 
macrophages in a 24-well plate (at an approximate MOI 10,000). 
Real-Time PCR Assays 
The PCR primers used to amplify and detect the various viral DNA 
intermediates are described below and their coordinates within the R73 plasmid 
used in these experiments is indicated. 
Early reverse transcription assay—forward primer: 
5'-TCTCTGGCTAACTAGGGAACCCACTGCTT-3'(bpl81-209 in R region of 
LTR), 491-519 in R73 
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reverse primer: 5'-TGACTAAAAGGGTCTGAGGGATCTCTAGTTACCAG-3', 
(bp271-302 in U5 region of LTR) 581-613 in R73 molecular beacon: 56-FAM-5'-
CCGAACCAGTAGTGTGTGCCCGTCTGTTGTGTGGTTCGG-3'-Dabcyl(bp243 
-266 in U5 region of LTR) 552-576 in R73 
Late reverse transcription assay—forward primer: 
5'-AGATCCCTCAGACCCTTTTAGTCAGTGTGG-3'(592-621), 
reverse primer: 5'-GCCGCCCCTCGCCTCTTG-3', (721-738) 
beacon: 56-FAM-5'-CCGACCCTCTCGACGCAGGACTCGGCTTGGGTCGG-3'-
Dabcyl. 684-705 
2-LTR circle assay—forward primer: 
5'-CTCAGACCCTTTTAGTCAGTGTGGAAAATCTCTA-3', reverse primer: 5'-
TGACCCCTGGCCCTGGTGTGTAG-3', beacon: 56-FAM-5'-
CCGCACCTACCACACACAAGGCTACTTCGTGCGG-3'-Dabcyl. 53-74 in R73 
CCR5 assay—forward primer: 
5'-TCATTACACCTGCAGCTCTCATTTTCCATACAGTC-3', 
reverse primer: 5'-CACCGAAGCAGAGTTTTTAGGATTCCCGAGTA-3', 
beacon: 56-FAM-5'-GCGCCTATGACAAGCAGCGGCAGGAGGCGC-3'-Dabcyl. 
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Contamination control -forward primer: 
5'- TACTCTAAACCTGTGATTCCTC-3' 119-140 in R73 plasmid "backbone" 
reverse primer: 5'-TGACCCCTGGCCCTGGTGTGTAG-3', 289-311 
beacon: 56-FAM-5'-CCGCACCTACCACACACAAGGCTACTTCGTGCGG-3'-
Dabcyl. 
For each reaction, five microliters (approximately lOOng) of total genomic DNA 
was added to 45\iL of PCR mastermix containing IX PCR buffer II (Perkin 
Elmer), IX ROX internal passive reference buffer, 200nM dNTPs, 400 nM 
primers, 200nM molecular beacon, and 1 U AmpliTaq Gold (Perkin Elmer) in 
each well of a 96-well PCR reaction plate. After an initial denaturation step (94°C 
for 10 minutes), PCR amplification proceeded for 50 cycles (94°C for 15 sec; 60°C 
for 30 sec; 72°C for 30 sec) in a Perkin Elmer ABI Prism 7700 sequence detection 
system. Copy numbers for all samples were determined by extrapolation from a 
plot of PCR standards using the ABI Prism 7700 SDS quantification software. 
Immunocytochemistry and Basic Fluorescence Microscopy 
Cells were grown on poly-L-lysine (Sigma)-treated glass coverslips. After 
transfection, cells were fixed with 3% electron-microscopy grade para-
formaldehyde (Tosoumis) in PBS, and, in some cases, stained using mouse 
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monoclonal antibodies to IN (generally mAb6G5, N I H AIDS reagent repository), 
and either a tyramide-based amplification with anti-HRP antibodies (TSA kit, 
AppliedBiosystems) or, in the case of Nup358 staining, a biotinylated anti-rabbit 
antibody conjugated to a streptavidin-linked quantum dot 655 (qDots Inc). 
Coverslips were mounted in medium containing DAPI (Vectashield, Vector 
Laboratories). EGFP, DAPI and antibody fluorescence were visualized using 
deconvolution, restoration microscopy (DeltaVision, Applied Precision). In the 
case of nucleofected cells, dendritic cells and T cells were resuspended in serum-
free RPMI (lOOul) and adhered to alcian blue coated glass coverslips for 5 
minutes at 37°C, then 2 minutes at 4°C, fix with 3% paraformaldehyde, and 
inverted onto glass slides with DAPI containing mounting medium (Vectashield). 
Viral Infections 
Macrophage and PBL infections 
Virus was added to confluent a monolayer of macrophage (approximately 2.0 x 
IO5 cells) or activated PBLs (1.0 x IO6) in 24-well format and infection enhanced 
by spinoculation. Briefly, the technique of spinoculation involves spinning the 
virus particles (in media containing Fetal Bovine Serum) down onto the 
monolayer of macrophages or other cells by centrifugation for 90 minutes at 2300 
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rpm at room temperature. This technique increases the amount of virus that 
contacts the cell surface and enhances the rate of infection in the cultures. 
Generally cells were infected with between 250-50ng p24 of HIV viruses or 
lentiviral vector stocks, with no large differences apparent in downstream assays 
(i.e. Real Time PCR) when the spinoculation technique was used. Following 
spinoculation, infected cells were washed thoroughly (at least 3 times) with PBS 
to remove free virions and excess contaminating viral DNA from the transfected 
stocks. Fresh media was added back to all washed infected cells. Inhibitors used 
include lOmM UC78154 (in PBS), 5mM L-731,988 (in DMSO) . Total nucleic acid 
was obtained using the QIAmp Blood Kit according to the manufacturer's 
protocol (Qiagen). 
Digitonin-permeabilized macrophage nuclear import assays 
Primary human macrophages were grown on glass coverslips in 24-well tissue 
culture plates. Cells were washed twice with ice-cold IX transport buffer (20mM 
HEPES, HOmM potassium acetate, 2mM magnesium acetate, and 0.5mM EGTA) 
with IX protease inhibitors (EDTA-free mini complete tablets, Roche), and then 
permeabilized for 5 minutes on ice in transport buffer containing 45|Jg/ml high-
purity digitonin (Calbiochem). After one wash in transport buffer, slides (with 
permeabilized macrophages) were removed from the wells of the tissue culture 
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plate and inverted onto 30ul nuclear import reactions containing lOul cell extract 
(from Xenopus oocytes or HeLa cells), l[il of 20X stock of an energy-regenerating 
system (ImM ATP, ImM GTP, 2mM creatine phosphate, 40 U/ml creatine 
phosphokinase), lpil of lOmM GTP, 1|jM of recombinant protein of interest (or 
lOul PICs), and lu4 of recombinant Ran. Nuclear import reactions were 
incubated at 37°C for 2 hours, then cells were washed twice with IX transport 
buffer, once in PBS, fixed with 3% PFA and immunostained and visualized as 
described above. 
PIC Immunoprecipitations 
To generate PIC from infected macrophage cytosol, three million monocytes were 
plated in T25 flasks (Falcon), incubated at 37°C for six days in Rl media, and 
media was changed to DMEM/ 10%FBS on day 7. In a Biosafety Level 2+ facility 
and inside of a tissue culture hood, primary human macrophages were infected 
with 3|Jg R73-Yu2 virus stock in 3ml culture media, and incubated for 12 hours, 
to allow reverse transcription to occur. Then, virus was washed off of cells with 
PBS (a total of 4 washes, 6ml volume per wash), and cells were incubated in 3ml 
hypotonic lysis buffer A (lOmM HEPES, 1.5mM MgC12, 5mM KCI, 5mM DTT, IX 
protease inhibitors, and 50ug/ml digitonin (CalbioChem)) for 1 minute, then 
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buffer was removed, and 1ml of hypotonic lysis buffer A was added back to the 
infected cells. The flask was then incubated on ice for 30 minutes, then lysed 
cells were removed from the flask with a cell scraper, and the 1ml of infected cell 
lysate was collected in a 1.5ml microfuge tube. A small piece of parafilm was 
placed over the mouth of the tube to reduce aerosol formation. The infected cell 
lysate was then homogenized by passing it through a blunt-ended 23 gauge 
needle attached to a 1 cc syringe for 5-10 minutes (about 50-100 times). The 
homogenized lysate was then centrifuged at 6000 rpm for 5 minutes at 4°C to 
pellet the cell nuclei. The supernatant was removed, placed in a new tube, and 
centrifuged at 10,000 rpm for 10 minutes at 4°C. The clarified supernatant 
("PICs") was then collected and stored in 100ul aliquots in a -80°C freezer until 
use. 
Empigen-extracted rat liver nucleoporins were made by detergent solubilization 
of rat liver nuclear envelopes obtained from Elias Coutavas in the Blobel lab 
(prepared as previously described by Blobel and Potter, 1966). Briefly, three 
hundred million nuclei were thawed and pelleted at 3000 rpm for 1 minute. 
Pelleted nuclei were resuspended with constant vortexing at a final concentration 
of 100 U/ml 1 by drop-wise addition of buffer A (O.lmM MgCi2, ImM DTT, 
0.5mM PMSF, 1 Mg/ml_1 leupeptin/pepstatin/aprotinin) supplemented with 
5ug/mH DNase I and Sug/mF RNase A. After resuspension, nuclei were 
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immediately diluted to 20 U/mh1 by addition of buffer B (buffer A 10% sucrose, 
20mM triethanolamine, pH 8.5) with constant vortexing. After digestion at room 
temperature for 15 minutes, the suspension was underlayed with 4ml ice-cold 
buffer C (buffer A 30% sucrose, 20mM triethanolamine, pH 7.5) and centrifuged 
at 3,500 g for 10 minutes in a swinging bucket rotor (Sorvall SH-3000). The pellet 
was resuspended in ice-cold buffer D (buffer A 10% sucrose, 20mM 
triethanolamine, pH 7.5) at a final concentration of 100 U/ml-1. The suspension 
was diluted to 67 U/mL1 with buffer D 0.3 mg/ml-1 heparin (Sigma), and then 
immediately underlayed and pelleted as above. The heparin pellet was 
resuspended in ice-cold buffer D (100 U/ ml-1), diluted to 67 U/ ml-1 with buffer 
D+3% Triton X-100 (Sigma), and 0.075% SDS, then pelleted as above. The pellet 
(the NPC-lamina fraction) was then resuspended in buffer D+0.3% Empigen 
(CalbioChem) (final concentration of 100 U/ml-1). After incubation on ice for 10 
minutes, the insoluble lamina was separated from soluble nucleoporins by 
centrifugation in a microfuge at 12,000 rpm for 15 minutes. The supernatant, 
containing the Empigen-extracted rat liver nucleoporins was then collected, snap 
frozen in liquid nitrogen, and stored in 100ul aliquots at -80°C until use. 
For the immunoprecipitations, lOOtil of thawed PICs was added to lOOul of 
Empigen-extracted rat liver nuclei. This mixture was then used "pre-cleared" 
with Protein A/G sepharose beads (Santa Cruz Biotech) by adding 20nl of beads 
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per 200ul of sample, incubating at 4°C on a rotator, then centrigufing at 
14,000rpm for 1 minute. Monoclonal antibodies to the N-terminus of HIV 
integrase (1:100 dilution of mAb-6G5, NIH AIDS repository) were then added to 
each sample, along with 20ul of PBS-washed Protein A/G beads. 
Immunoprecipitation reactions were incubated at 4°C for 3 hours on a rotator, 
then beads were harvested by centrifugation at 14,000 rpm for 1 minute. The 
beads were washed six times with 400 ul of IP buffer (IX Tris-buffered saline 
(TBS) + IX protease inhibitors + O.lmM MgCl2), then 50ul of 2X Laemmli sample 
buffer (BioRad, supplemented with ImM DTT) was added to each sample, then 
tubes were incubated at 95°C for 5 minutes on a heat block. Samples were then 
electrophoresed on 4-20% Tris-Glycine gels (Invitrogen), transferred onto 
nitrocellulose (Amersham), and analysed by standard western blotting 
procedures (IX Tris-Glycine transfer buffer, with 10% methanol and 0.1% SDS, 
Invitrogen, then transferred for 2 hours at a constant 30V) using the anti-FG 
nucleoporin monoclonal antibody mAb-414 from the Blobel lab (1:2000 dilution). 
Ligand blot assays 
For the ligand blot assays, 1 x IO6 rat liver nuclei were run out in each well of a 
15-well 4-20% Tris-Glycine gel, then transferred to nitrocellulose by western 
blotting as above. The blot was then blocked for 1 hour with 3% non-fat dry milk 
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(BioRad) and then cut by well into 15 strips. Each strip was air-dried, then added 
face up to each well of an 8-well plate (Costar). Using both wild type and NLS 
mutant version of recombinant HIV integrase (kindly provided by Dr. Daria 
Hazuda, Merck & Co., Inc.) at a final concentration of luM per well, 1ml of 
recombinant protein solution was added to each strip. The strips were then 
washed six times with 2ml of IP buffer, and incubated for 1 hour at room 
temperature with 1ml of a 1:500 dilution of mAb-6G5 also in IP buffer. The strips 
were then washed again, and incubated for 30 minutes with a goat-anti-mouse-
horseradish peroxidase-conjugated secondary antibody (Pharmacia) at a 1:40,000 
dilution. Bound HIV integrase was then detected by developing the strips with 
the Super-signal West-Pico HRP substrate reagent (Pierce), according to the 
manufacturer's protocol. 
Live-Cell Imaging with Vpr-GFP viruses 
Primary human macrophages were grown in special Petri dishes with embedded 
glass slides (Matek, Inc.). Prior to addition of Vpr-virus stocks (made in HEK 
293T cells as above, by co-transfecting viral constructs lacking the Vpr gene with 
plasmids encoding Vpr-GFP), the Petri dish of macrophages was mounted onto 
an Axioplan microscope (Zeiss) equipped with a spinning-disk laser confocal set 
up and a heated chamber (37°C). D116A and K236/240A NLS mutant viruses 
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were added (3ug p24 of each virus, 3ml total volume, approximate M O I of 
10,000) and focus was adjusted until optimal fields of virions and cells were 
attained. Once an optimal field was identified, the microscope software was 
programmed to image the cells over a defined duration (16 hours) at 5-minute 
intervals through a range of Z series positions through the cell. At the end of the 
16-hour infection period, images from the middle section of the Z series 
(representing the center of the cell with relation to the top and bottom of the 
culture dish) were compiled into live-motion movies using the imaging software 
(MetaMorph 6.0, Universal Imaging Systems) showing virus dynamics inside of 
live cells. 
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chaptfr -i. appendix and glossary of terms and Abbreviations 
AIDS Acquired Immune Deficiency Syndrome 
BAF Barrier to Autiointegration Factor 
CA Capsid 
CMV Cytomegalovirus 
cPPT Central Polypurine Tract 
EGFP Enhanced Green Fluorescent Protein 
56FAM 56-carboxyfluorescein 
GST Glutathione S-Transferase 
HIV-1 Human Immunodeficiency Virus type 1 
HMG High Mobility Group Protein 
IN Integrase 
Kap ex Karyopherin a 
Kap P Karyopherin P 
LTR Long Terminal Repeat 
MA Matrix 
MBP Maltose-Binding Protein 
MLV Moloney Leukemia Virus 
NC Nucleocapsid 
NFAT-1 Nuclear Factor of Activated T-cells -1 
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N L S Nuclear Localization Signal 
NPC Nuclear Pore Complex 
Nup Nucleoporin 
PBL Peripheral Blood Lymphocytes 
PBS Phosphate Buffered Saline 
PCR Polymerase Chain Reaction 
PIC Pre-integration Complex 
PFA Paraformaldehyde 
PR Protease 
RRE Rev-Responsive Element 
RT Reverse Transcriptase 
SIV Simian Immunodeficiency Virus 
TAR Tat-Activated Region 
WGA Wheat Germ Agglutinin 
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